{"title": "Adenosine triphosphate", "authors": [], "time_published": "2020-01-31T06:19:08Z", "sections": [{"title": "", "paragraphs": "{{short description|chemical compound}}\n{{chembox\n| Watchedfields = changed\n| verifiedrevid = 477228486\n| Name = Adenosine-5'-triphosphate\n| ImageFile = Adenosintriphosphat protoniert.svg\n| ImageSize = 200px\n|Section1={{Chembox Identifiers\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank = DB00171\n| ChEBI_Ref = {{ebicite|correct|EBI}}\n| ChEBI = 15422\n| KEGG_Ref = {{keggcite|correct|kegg}}\n| KEGG = C00002\n| SMILES = O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n2cnc1c(ncnc12)N)[C@H](O)[C@@H]3O\n| InChIKey = ZKHQWZAMYRWXGA-KQYNXXCUBG\n| PubChem = 5957\n| IUPHAR_ligand = 1713\n| SMILES1 = c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = ZKHQWZAMYRWXGA-KQYNXXCUSA-N\n| CASNo_Ref = {{cascite|correct|CAS}}\n| CASNo = 56-65-5\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 8L70Q75FXE\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 14249\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 5742\n }}\n| Section2={{Chembox Properties\n|   C=10|H=16|N=5|O=13|P=3\n|   MolarMass = 507.180182018  g/mol\n|   MeltingPtC = 187\n|   MeltingPt_notes = disodium&nbsp;salt; decomposes\n|   Density = 1.04 g/cm<sup>3</sup> (disodium salt)\n|   pKa = 6.5\n| LambdaMax = 259 nm<ref name=\"lamda_source_1\">{{cite web |title=Adenosine 5'-triphosphate disodium salt Product Information |url=https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf |publisher=Sigma |access-date=2019-03-22 |archive-url=https://web.archive.org/web/20190323054630/https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf |archive-date=2019-03-23 |url-status=live }}</ref>\n| Absorbance = [[Molar attenuation coefficient|\u03b5<sub>259</sub>]] = 15.4 mM<sup>\u22121</sup> cm<sup>\u22121</sup> <ref name=\"lamda_source_1\" />\n }}\n}}\n{{more citations needed|date=September 2017}}\n'''Adenosine triphosphate''' ('''ATP''') is a complex [[organic compound|organic chemical]] that provides energy to drive many processes in living [[cell (biology)|cells]], e.g. muscle contraction, nerve impulse propagation, and chemical synthesis. Found in all forms of life, ATP is often referred to as the \"molecular unit of [[currency]]\" of intracellular [[energy transfer]].<ref>{{cite journal |last=Knowles |first=J.&nbsp;R. |title=Enzyme-catalyzed phosphoryl transfer reactions |journal=Annu. Rev. Biochem. |volume=49 |pages=877\u2013919 |year=1980 |pmid=6250450 | doi=10.1146/annurev.bi.49.070180.004305}}</ref>  When consumed in [[Metabolism|metabolic]] processes, it converts either to [[adenosine diphosphate]] (ADP) or to [[adenosine monophosphate]] (AMP). Other processes regenerate ATP so that the human body recycles its own body weight equivalent in ATP each day.<ref>{{cite journal |last1=T\u00f6rnroth-Horsefield |first1=S. |last2=Neutze |first2=R. |title=Opening and closing the metabolite gate |journal=Proc. Natl. Acad. Sci. USA |volume=105 |issue=50 |pages=19565\u201319566 |date=December 2008|pmid=19073922 |doi=10.1073/pnas.0810654106 |pmc=2604989}}</ref>  It is also a [[Precursor (chemistry)|precursor]] to DNA and RNA, and is used as a [[coenzyme]].\n\nFrom the perspective of [[biochemistry]], ATP is classified as a [[nucleoside triphosphate]], which indicates that it consists of three components: a nitrogenous base ([[adenine]]), the sugar [[ribose]], and the [[Polyphosphate|triphosphate]].\n\n", "attributes": [{"name": "short description", "values": [{"name": "1", "value": "chemical compound"}]}, {"name": "chembox\n", "values": [{"name": "Watchedfields", "value": "changed"}, {"name": "verifiedrevid", "value": "477228486"}, {"name": "Name", "value": "Adenosine-5'-triphosphate"}, {"name": "ImageFile", "value": "Adenosintriphosphat protoniert.svg"}, {"name": "ImageSize", "value": "200px"}, {"name": "Section1", "value": "{{Chembox Identifiers\n| DrugBank_Ref = {{drugbankcite|correct|drugbank}}\n| DrugBank = DB00171\n| ChEBI_Ref = {{ebicite|correct|EBI}}\n| ChEBI = 15422\n| KEGG_Ref = {{keggcite|correct|kegg}}\n| KEGG = C00002\n| SMILES = O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n2cnc1c(ncnc12)N)[C@H](O)[C@@H]3O\n| InChIKey = ZKHQWZAMYRWXGA-KQYNXXCUBG\n| PubChem = 5957\n| IUPHAR_ligand = 1713\n| SMILES1 = c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N\n| StdInChI_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChI = 1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1\n| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}\n| StdInChIKey = ZKHQWZAMYRWXGA-KQYNXXCUSA-N\n| CASNo_Ref = {{cascite|correct|CAS}}\n| CASNo = 56-65-5\n| UNII_Ref = {{fdacite|correct|FDA}}\n| UNII = 8L70Q75FXE\n| ChEMBL_Ref = {{ebicite|correct|EBI}}\n| ChEMBL = 14249\n| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}\n| ChemSpiderID = 5742\n }}"}, {"name": "Section2", "value": "{{Chembox Properties\n|   C=10|H=16|N=5|O=13|P=3\n|   MolarMass = 507.180182018  g/mol\n|   MeltingPtC = 187\n|   MeltingPt_notes = disodium&nbsp;salt; decomposes\n|   Density = 1.04 g/cm<sup>3</sup> (disodium salt)\n|   pKa = 6.5\n| LambdaMax = 259 nm<ref name=\"lamda_source_1\">{{cite web |title=Adenosine 5'-triphosphate disodium salt Product Information |url=https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf |publisher=Sigma |access-date=2019-03-22 |archive-url=https://web.archive.org/web/20190323054630/https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf |archive-date=2019-03-23 |url-status=live }}</ref>\n| Absorbance = [[Molar attenuation coefficient|\u03b5<sub>259</sub>]] = 15.4 mM<sup>\u22121</sup> cm<sup>\u22121</sup> <ref name=\"lamda_source_1\" />\n }}"}]}, {"name": "Chembox Identifiers\n", "values": [{"name": "DrugBank_Ref", "value": "{{drugbankcite|correct|drugbank}}"}, {"name": "DrugBank", "value": "DB00171"}, {"name": "ChEBI_Ref", "value": "{{ebicite|correct|EBI}}"}, {"name": "ChEBI", "value": "15422"}, {"name": "KEGG_Ref", "value": "{{keggcite|correct|kegg}}"}, {"name": "KEGG", "value": "C00002"}, {"name": "SMILES", "value": "O=P(O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n2cnc1c(ncnc12)N)[C@H](O)[C@@H]3O"}, {"name": "InChIKey", "value": "ZKHQWZAMYRWXGA-KQYNXXCUBG"}, {"name": "PubChem", "value": "5957"}, {"name": "IUPHAR_ligand", "value": "1713"}, {"name": "SMILES1", "value": "c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N"}, {"name": "StdInChI_Ref", "value": "{{stdinchicite|correct|chemspider}}"}, {"name": "StdInChI", "value": "1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1"}, {"name": "StdInChIKey_Ref", "value": "{{stdinchicite|correct|chemspider}}"}, {"name": "StdInChIKey", "value": "ZKHQWZAMYRWXGA-KQYNXXCUSA-N"}, {"name": "CASNo_Ref", "value": "{{cascite|correct|CAS}}"}, {"name": "CASNo", "value": "56-65-5"}, {"name": "UNII_Ref", "value": "{{fdacite|correct|FDA}}"}, {"name": "UNII", "value": "8L70Q75FXE"}, {"name": "ChEMBL_Ref", "value": "{{ebicite|correct|EBI}}"}, {"name": "ChEMBL", "value": "14249"}, {"name": "ChemSpiderID_Ref", "value": "{{chemspidercite|correct|chemspider}}"}, {"name": "ChemSpiderID", "value": "5742"}]}, {"name": "drugbankcite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "drugbank"}]}, {"name": "ebicite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "EBI"}]}, {"name": "keggcite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "kegg"}]}, {"name": "stdinchicite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "chemspider"}]}, {"name": "stdinchicite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "chemspider"}]}, {"name": "cascite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "CAS"}]}, {"name": "fdacite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "FDA"}]}, {"name": "ebicite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "EBI"}]}, {"name": "chemspidercite", "values": [{"name": "1", "value": "correct"}, {"name": "2", "value": "chemspider"}]}, {"name": "Chembox Properties\n", "values": [{"name": "C", "value": "10"}, {"name": "H", "value": "16"}, {"name": "N", "value": "5"}, {"name": "O", "value": "13"}, {"name": "P", "value": "3"}, {"name": "MolarMass", "value": "507.180182018  g/mol"}, {"name": "MeltingPtC", "value": "187"}, {"name": "MeltingPt_notes", "value": "disodium&nbsp;salt; decomposes"}, {"name": "Density", "value": "1.04 g/cm<sup>3</sup> (disodium salt)"}, {"name": "pKa", "value": "6.5"}, {"name": "LambdaMax", "value": "259 nm<ref name=\"lamda_source_1\">{{cite web |title=Adenosine 5'-triphosphate disodium salt Product Information |url=https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf |publisher=Sigma |access-date=2019-03-22 |archive-url=https://web.archive.org/web/20190323054630/https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf |archive-date=2019-03-23 |url-status=live }}</ref>"}, {"name": "Absorbance", "value": "[[Molar attenuation coefficient|\u03b5<sub>259</sub>]] = 15.4 mM<sup>\u22121</sup> cm<sup>\u22121</sup> <ref name=\"lamda_source_1\" />"}]}, {"name": "cite web ", "values": [{"name": "title", "value": "Adenosine 5'-triphosphate disodium salt Product Information"}, {"name": "url", "value": "https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf"}, {"name": "publisher", "value": "Sigma"}, {"name": "access-date", "value": "2019-03-22"}, {"name": "archive-url", "value": "https://web.archive.org/web/20190323054630/https://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/Sigma/Product_Information_Sheet/a7699pis.pdf"}, {"name": "archive-date", "value": "2019-03-23"}, {"name": "url-status", "value": "live"}]}, {"name": "more citations needed", "values": [{"name": "date", "value": "September 2017"}]}, {"name": "cite journal ", "values": [{"name": "last", "value": "Knowles"}, {"name": "first", "value": "J.&nbsp;R."}, {"name": "title", "value": "Enzyme-catalyzed phosphoryl transfer reactions"}, {"name": "journal", "value": "Annu. Rev. Biochem."}, {"name": "volume", "value": "49"}, {"name": "pages", "value": "877\u2013919"}, {"name": "year", "value": "1980"}, {"name": "pmid", "value": "6250450"}, {"name": "doi", "value": "10.1146/annurev.bi.49.070180.004305"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "T\u00f6rnroth-Horsefield"}, {"name": "first1", "value": "S."}, {"name": "last2", "value": "Neutze"}, {"name": "first2", "value": "R."}, {"name": "title", "value": "Opening and closing the metabolite gate"}, {"name": "journal", "value": "Proc. Natl. Acad. Sci. USA"}, {"name": "volume", "value": "105"}, {"name": "issue", "value": "50"}, {"name": "pages", "value": "19565\u201319566"}, {"name": "date", "value": "December 2008"}, {"name": "pmid", "value": "19073922"}, {"name": "doi", "value": "10.1073/pnas.0810654106"}, {"name": "pmc", "value": "2604989"}]}], "id": 0}, {"title": "Structure", "paragraphs": "In terms of its structure, ATP consists of an [[adenine]] attached by the 9-nitrogen atom to the 1\u2032 carbon atom of a sugar ([[ribose]]), which in turn is attached at the 5' carbon atom of the sugar to a triphosphate group. In its many reactions related to metabolism, the adenine and sugar groups remain unchanged, but the triphosphate is converted to di- and monophosphate, giving respectively the derivatives [[adenosine diphosphate|ADP]] and [[adenosine monophosphate|AMP]]. The three phosphoryl groups are referred to as the alpha (\u03b1), beta (\u03b2), and, for the terminal phosphate, gamma (\u03b3).\n\nIn neutral solution, ionized ATP exists mostly as ATP<sup>4\u2212</sup>, with a small proportion of ATP<sup>3\u2212</sup>.<ref name=Storer>{{cite journal |last1=Storer |first1=A.|authorlink2=Athel Cornish-Bowden |last2=Cornish-Bowden |first2=A. | title = Concentration of MgATP<sup>2\u2212</sup> and other ions in solution. Calculation of the true concentrations of species present in mixtures of associating ions | pmc=1164030 | journal = Biochem. J. | volume = 159 | issue = 1 | pages = 1\u20135 | year = 1976 | pmid = 11772 | doi=10.1042/bj1590001}}</ref>\n\n===Binding of metal cations to ATP===\nBeing polyanionic and featuring a potentially [[chelation|chelatable]] polyphosphate group, ATP binds metal cations with high affinity. The [[binding constant]] for {{chem|link=magnesium|Mg|2+}} is ({{gaps|9|554}}).<ref>{{cite journal |last1=Wilson |first1=J. |last2=Chin |first2=A. | title = Chelation of divalent cations by ATP, studied by titration calorimetry | journal = Anal. Biochem. | volume = 193 | issue = 1 | pages = 16\u201319 | year = 1991 | pmid = 1645933| doi=10.1016/0003-2697(91)90036-S}}</ref>  The binding of a [[divalent]] [[cation]], almost always [[magnesium]], strongly affects the interaction of ATP with various proteins. Due to the strength of the ATP-Mg<sup>2+</sup> interaction, ATP exists in the cell mostly as a complex with {{chem|Mg|2+}} bonded to the phosphate oxygen centers.<ref name=Storer/><ref>{{cite journal |last1=Garfinkel |first1=L. |last2=Altschuld |first2=R. |last3=Garfinkel |first3=D. | title = Magnesium in cardiac energy metabolism | journal = J. Mol. Cell. Cardiol. | volume = 18 | issue = 10 | pages = 1003\u20131013 | year = 1986 | pmid = 3537318 | doi = 10.1016/S0022-2828(86)80289-9 }}</ref>\n\nA second magnesium ion is critical for ATP binding in the kinase domain.<ref name=\"Saylor\">{{cite journal |last1=Saylor |first1=P. |last2=Wang |first2=C. |last3=Hirai |first3=T. |last4=Adams |first4=J. | title = A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps | journal = Biochemistry | volume = 37 | issue = 36 | pages = 12624\u201312630 | year = 1998 | pmid = 9730835 | doi = 10.1021/bi9812672 }}</ref> The presence of Mg<sup>2+</sup> regulates kinase activity.<ref name=Lin>{{cite journal |last1=Lin |first1=X. |last2=Ayrapetov |first2=M |last3=Sun |first3=G. | title = Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator |pmc=1316873 | doi = 10.1186/1471-2091-6-25 | journal = BMC Biochem. | volume = 6 | pages = 25 | year = 2005| pmid = 16305747}}</ref>\n\n", "attributes": [{"name": "cite journal ", "values": [{"name": "last1", "value": "Storer"}, {"name": "first1", "value": "A."}, {"name": "authorlink2", "value": "Athel Cornish-Bowden"}, {"name": "last2", "value": "Cornish-Bowden"}, {"name": "first2", "value": "A."}, {"name": "title", "value": "Concentration of MgATP<sup>2\u2212</sup> and other ions in solution. Calculation of the true concentrations of species present in mixtures of associating ions"}, {"name": "pmc", "value": "1164030"}, {"name": "journal", "value": "Biochem. J."}, {"name": "volume", "value": "159"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "1\u20135"}, {"name": "year", "value": "1976"}, {"name": "pmid", "value": "11772"}, {"name": "doi", "value": "10.1042/bj1590001"}]}, {"name": "chem", "values": [{"name": "link", "value": "magnesium"}, {"name": "1", "value": "Mg"}, {"name": "2", "value": "2+"}]}, {"name": "gaps", "values": [{"name": "1", "value": "9"}, {"name": "2", "value": "554"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Wilson"}, {"name": "first1", "value": "J."}, {"name": "last2", "value": "Chin"}, {"name": "first2", "value": "A."}, {"name": "title", "value": "Chelation of divalent cations by ATP, studied by titration calorimetry"}, {"name": "journal", "value": "Anal. Biochem."}, {"name": "volume", "value": "193"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "16\u201319"}, {"name": "year", "value": "1991"}, {"name": "pmid", "value": "1645933"}, {"name": "doi", "value": "10.1016/0003-2697(91)90036-S"}]}, {"name": "chem", "values": [{"name": "1", "value": "Mg"}, {"name": "2", "value": "2+"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Garfinkel"}, {"name": "first1", "value": "L."}, {"name": "last2", "value": "Altschuld"}, {"name": "first2", "value": "R."}, {"name": "last3", "value": "Garfinkel"}, {"name": "first3", "value": "D."}, {"name": "title", "value": "Magnesium in cardiac energy metabolism"}, {"name": "journal", "value": "J. Mol. Cell. Cardiol."}, {"name": "volume", "value": "18"}, {"name": "issue", "value": "10"}, {"name": "pages", "value": "1003\u20131013"}, {"name": "year", "value": "1986"}, {"name": "pmid", "value": "3537318"}, {"name": "doi", "value": "10.1016/S0022-2828(86)80289-9"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Saylor"}, {"name": "first1", "value": "P."}, {"name": "last2", "value": "Wang"}, {"name": "first2", "value": "C."}, {"name": "last3", "value": "Hirai"}, {"name": "first3", "value": "T."}, {"name": "last4", "value": "Adams"}, {"name": "first4", "value": "J."}, {"name": "title", "value": "A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps"}, {"name": "journal", "value": "Biochemistry"}, {"name": "volume", "value": "37"}, {"name": "issue", "value": "36"}, {"name": "pages", "value": "12624\u201312630"}, {"name": "year", "value": "1998"}, {"name": "pmid", "value": "9730835"}, {"name": "doi", "value": "10.1021/bi9812672"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Lin"}, {"name": "first1", "value": "X."}, {"name": "last2", "value": "Ayrapetov"}, {"name": "first2", "value": "M"}, {"name": "last3", "value": "Sun"}, {"name": "first3", "value": "G."}, {"name": "title", "value": "Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator"}, {"name": "pmc", "value": "1316873"}, {"name": "doi", "value": "10.1186/1471-2091-6-25"}, {"name": "journal", "value": "BMC Biochem."}, {"name": "volume", "value": "6"}, {"name": "pages", "value": "25"}, {"name": "year", "value": "2005"}, {"name": "pmid", "value": "16305747"}]}], "id": 1}, {"title": "Binding of metal cations to ATP", "paragraphs": "Being polyanionic and featuring a potentially [[chelation|chelatable]] polyphosphate group, ATP binds metal cations with high affinity. The [[binding constant]] for {{chem|link=magnesium|Mg|2+}} is ({{gaps|9|554}}).<ref>{{cite journal |last1=Wilson |first1=J. |last2=Chin |first2=A. | title = Chelation of divalent cations by ATP, studied by titration calorimetry | journal = Anal. Biochem. | volume = 193 | issue = 1 | pages = 16\u201319 | year = 1991 | pmid = 1645933| doi=10.1016/0003-2697(91)90036-S}}</ref>  The binding of a [[divalent]] [[cation]], almost always [[magnesium]], strongly affects the interaction of ATP with various proteins. Due to the strength of the ATP-Mg<sup>2+</sup> interaction, ATP exists in the cell mostly as a complex with {{chem|Mg|2+}} bonded to the phosphate oxygen centers.<ref name=Storer/><ref>{{cite journal |last1=Garfinkel |first1=L. |last2=Altschuld |first2=R. |last3=Garfinkel |first3=D. | title = Magnesium in cardiac energy metabolism | journal = J. Mol. Cell. Cardiol. | volume = 18 | issue = 10 | pages = 1003\u20131013 | year = 1986 | pmid = 3537318 | doi = 10.1016/S0022-2828(86)80289-9 }}</ref>\n\nA second magnesium ion is critical for ATP binding in the kinase domain.<ref name=\"Saylor\">{{cite journal |last1=Saylor |first1=P. |last2=Wang |first2=C. |last3=Hirai |first3=T. |last4=Adams |first4=J. | title = A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps | journal = Biochemistry | volume = 37 | issue = 36 | pages = 12624\u201312630 | year = 1998 | pmid = 9730835 | doi = 10.1021/bi9812672 }}</ref> The presence of Mg<sup>2+</sup> regulates kinase activity.<ref name=Lin>{{cite journal |last1=Lin |first1=X. |last2=Ayrapetov |first2=M |last3=Sun |first3=G. | title = Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator |pmc=1316873 | doi = 10.1186/1471-2091-6-25 | journal = BMC Biochem. | volume = 6 | pages = 25 | year = 2005| pmid = 16305747}}</ref>\n\n", "attributes": [{"name": "chem", "values": [{"name": "link", "value": "magnesium"}, {"name": "1", "value": "Mg"}, {"name": "2", "value": "2+"}]}, {"name": "gaps", "values": [{"name": "1", "value": "9"}, {"name": "2", "value": "554"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Wilson"}, {"name": "first1", "value": "J."}, {"name": "last2", "value": "Chin"}, {"name": "first2", "value": "A."}, {"name": "title", "value": "Chelation of divalent cations by ATP, studied by titration calorimetry"}, {"name": "journal", "value": "Anal. Biochem."}, {"name": "volume", "value": "193"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "16\u201319"}, {"name": "year", "value": "1991"}, {"name": "pmid", "value": "1645933"}, {"name": "doi", "value": "10.1016/0003-2697(91)90036-S"}]}, {"name": "chem", "values": [{"name": "1", "value": "Mg"}, {"name": "2", "value": "2+"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Garfinkel"}, {"name": "first1", "value": "L."}, {"name": "last2", "value": "Altschuld"}, {"name": "first2", "value": "R."}, {"name": "last3", "value": "Garfinkel"}, {"name": "first3", "value": "D."}, {"name": "title", "value": "Magnesium in cardiac energy metabolism"}, {"name": "journal", "value": "J. Mol. Cell. Cardiol."}, {"name": "volume", "value": "18"}, {"name": "issue", "value": "10"}, {"name": "pages", "value": "1003\u20131013"}, {"name": "year", "value": "1986"}, {"name": "pmid", "value": "3537318"}, {"name": "doi", "value": "10.1016/S0022-2828(86)80289-9"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Saylor"}, {"name": "first1", "value": "P."}, {"name": "last2", "value": "Wang"}, {"name": "first2", "value": "C."}, {"name": "last3", "value": "Hirai"}, {"name": "first3", "value": "T."}, {"name": "last4", "value": "Adams"}, {"name": "first4", "value": "J."}, {"name": "title", "value": "A second magnesium ion is critical for ATP binding in the kinase domain of the oncoprotein v-Fps"}, {"name": "journal", "value": "Biochemistry"}, {"name": "volume", "value": "37"}, {"name": "issue", "value": "36"}, {"name": "pages", "value": "12624\u201312630"}, {"name": "year", "value": "1998"}, {"name": "pmid", "value": "9730835"}, {"name": "doi", "value": "10.1021/bi9812672"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Lin"}, {"name": "first1", "value": "X."}, {"name": "last2", "value": "Ayrapetov"}, {"name": "first2", "value": "M"}, {"name": "last3", "value": "Sun"}, {"name": "first3", "value": "G."}, {"name": "title", "value": "Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator"}, {"name": "pmc", "value": "1316873"}, {"name": "doi", "value": "10.1186/1471-2091-6-25"}, {"name": "journal", "value": "BMC Biochem."}, {"name": "volume", "value": "6"}, {"name": "pages", "value": "25"}, {"name": "year", "value": "2005"}, {"name": "pmid", "value": "16305747"}]}], "id": 2}, {"title": "Chemical properties", "paragraphs": "Salts of ATP can be isolated as colorless solids.<ref>{{Merck13th}}</ref>\n[[File:ATP-ADP.svg|thumb|upright=1.5|The cycle of synthesis and degradation of ATP; 1 and 2 represent output and input of energy, respectively.]]\n\nATP is stable in aqueous solutions between pH&nbsp;6.8 and 7.4, in the absence of catalysts.  At more extreme pHs, it rapidly [[hydrolysis|hydrolyses]]  to [[adenosine diphosphate|ADP]] and phosphate. Living cells maintain the ratio of ATP to ADP at a point ten orders of magnitude from equilibrium, with ATP concentrations fivefold higher than the concentration of ADP.<ref name=Nicholls>{{cite book |last1=Ferguson |first1=S.&nbsp;J. |last2=Nicholls |first2=David |last3=Ferguson |first3=Stuart |title=Bioenergetics 3 |publisher=Academic |location=San Diego, CA |year=2002 |isbn=978-0-12-518121-1 |edition=3rd}}</ref><ref name=\"Stryer p376\">{{cite book |first1=J.&nbsp;M. |last1=Berg |first2=J.&nbsp; L. |last2=Tymoczko |first3=L. |last3=Stryer | title = Biochemistry |url=https://archive.org/details/biochemistry200100jere |url-access=registration | publisher = W.&nbsp;H. Freeman | year = 2003 | location = New York, NY | page = [https://archive.org/details/biochemistry200100jere/page/376 376] |isbn = 978-0-7167-4684-3}}</ref> In the context of biochemical reactions, the P-O-P bonds are frequently referred to as [[high-energy phosphate|''high-energy bonds'']].<ref>{{cite journal |last1=Chance|first1= B. |last2=Lees|first2= H. |last3=Postgate|first3= J.&nbsp;G. | title = The Meaning of \"Reversed Electron Flow\" and \"High Energy Electron\" in Biochemistry|doi=10.1038/238330a0|journal = Nature | volume = 238 | pages = 330\u2013331 | year = 1972 | pmid = 4561837 | issue = 5363 }}</ref>\n\nThe hydrolysis of ATP into ADP and inorganic phosphate releases 30.5&nbsp;[[joule per mole|kJ/mol]] of enthalpy, with a change in [[Thermodynamic free energy|free energy]] of 3.4&nbsp;kJ/mol.<ref>{{cite journal |last1=Gajewski |first1=E. |last2=Steckler |first2=D. |last3=Goldberg |first3=R. |title=Thermodynamics of the hydrolysis of adenosine 5\u2032-triphosphate to adenosine 5\u2032-diphosphate |url=http://www.jbc.org/cgi/reprint/261/27/12733.pdf |journal=J. Biol. Chem. |volume=261 |issue=27 |pages=12733\u201312737 |year=1986 |pmid=3528161 |access-date=2006-12-27 |archive-url=https://web.archive.org/web/20070927170509/http://www.jbc.org/cgi/reprint/261/27/12733.pdf |archive-date=2007-09-27 |url-status=live }}</ref> The energy released by cleaving either a phosphate (P<sub>i</sub>) or pyrophosphate (PP<sub>i</sub>) unit from ATP at [[standard state]] of 1&nbsp;M are:<ref>{{cite book |title=Biochemistry |last=Berg |first=Jeremy M. |last2=Tymoczko|first2= John L.|last3= Stryer|first3= Lubert |year=2007 |edition=6th |publisher=W.&nbsp;H. Freeman |location=New York, NY |isbn=978-0-7167-8724-2 |page=413}}</ref>\n\n:ATP + {{chem|H|2|O}} \u2192 ADP + P<sub>i</sub> {{pad|1em}} \u0394''G''\u00b0 = \u221230.5&nbsp;kJ/mol (\u22127.3&nbsp;kcal/mol)\n:ATP + {{chem|H|2|O}} \u2192 AMP + PP<sub>i</sub> {{pad|1em}} \u0394''G''\u00b0 = \u221245.6&nbsp;kJ/mol (\u221210.9&nbsp;kcal/mol)\nThese abbreviated equations can be written more explicitly (R = [[adenosine|adenosyl]]):\n:[RO-P(O)<sub>2</sub>-O-P(O)<sub>2</sub>-O-PO<sub>3</sub>]<sup>4\u2212</sup> + {{chem|H|2|O}} \u2192 [RO-P(O)<sub>2</sub>-O-PO<sub>3</sub>]<sup>3\u2212</sup> + [PO<sub>4</sub>]<sup>3\u2212</sup>  +  2 H<sup>+</sup>\n:[RO-P(O)<sub>2</sub>-O-P(O)<sub>2</sub>-O-PO<sub>3</sub>]<sup>4\u2212</sup> + {{chem|H|2|O}} \u2192 [RO-PO<sub>3</sub>]<sup>2\u2212</sup> + [O<sub>3</sub>P-O-PO<sub>3</sub>]<sup>4\u2212</sup>  +  2 H<sup>+</sup>\n\n[[File:MgATP2-small.gif|thumb|This image shows a 360-degree rotation of a single, gas-phase [[magnesium]]-ATP chelate with a charge of \u22122. The anion was optimized at the UB3LYP/6-311++G(d,p) theoretical level and the atomic connectivity modified by the human optimizer to reflect the probable electronic structure.]]\n\n", "attributes": [{"name": "cite book ", "values": [{"name": "last1", "value": "Ferguson"}, {"name": "first1", "value": "S.&nbsp;J."}, {"name": "last2", "value": "Nicholls"}, {"name": "first2", "value": "David"}, {"name": "last3", "value": "Ferguson"}, {"name": "first3", "value": "Stuart"}, {"name": "title", "value": "Bioenergetics 3"}, {"name": "publisher", "value": "Academic"}, {"name": "location", "value": "San Diego, CA"}, {"name": "year", "value": "2002"}, {"name": "isbn", "value": "978-0-12-518121-1"}, {"name": "edition", "value": "3rd"}]}, {"name": "cite book ", "values": [{"name": "first1", "value": "J.&nbsp;M."}, {"name": "last1", "value": "Berg"}, {"name": "first2", "value": "J.&nbsp; L."}, {"name": "last2", "value": "Tymoczko"}, {"name": "first3", "value": "L."}, {"name": "last3", "value": "Stryer"}, {"name": "title", "value": "Biochemistry"}, {"name": "url", "value": "https://archive.org/details/biochemistry200100jere"}, {"name": "url-access", "value": "registration"}, {"name": "publisher", "value": "W.&nbsp;H. Freeman"}, {"name": "year", "value": "2003"}, {"name": "location", "value": "New York, NY"}, {"name": "page", "value": "[https://archive.org/details/biochemistry200100jere/page/376 376]"}, {"name": "isbn", "value": "978-0-7167-4684-3"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Chance"}, {"name": "first1", "value": "B."}, {"name": "last2", "value": "Lees"}, {"name": "first2", "value": "H."}, {"name": "last3", "value": "Postgate"}, {"name": "first3", "value": "J.&nbsp;G."}, {"name": "title", "value": "The Meaning of \"Reversed Electron Flow\" and \"High Energy Electron\" in Biochemistry"}, {"name": "doi", "value": "10.1038/238330a0"}, {"name": "journal", "value": "Nature"}, {"name": "volume", "value": "238"}, {"name": "pages", "value": "330\u2013331"}, {"name": "year", "value": "1972"}, {"name": "pmid", "value": "4561837"}, {"name": "issue", "value": "5363"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Gajewski"}, {"name": "first1", "value": "E."}, {"name": "last2", "value": "Steckler"}, {"name": "first2", "value": "D."}, {"name": "last3", "value": "Goldberg"}, {"name": "first3", "value": "R."}, {"name": "title", "value": "Thermodynamics of the hydrolysis of adenosine 5\u2032-triphosphate to adenosine 5\u2032-diphosphate"}, {"name": "url", "value": "http://www.jbc.org/cgi/reprint/261/27/12733.pdf"}, {"name": "journal", "value": "J. Biol. Chem."}, {"name": "volume", "value": "261"}, {"name": "issue", "value": "27"}, {"name": "pages", "value": "12733\u201312737"}, {"name": "year", "value": "1986"}, {"name": "pmid", "value": "3528161"}, {"name": "access-date", "value": "2006-12-27"}, {"name": "archive-url", "value": "https://web.archive.org/web/20070927170509/http://www.jbc.org/cgi/reprint/261/27/12733.pdf"}, {"name": "archive-date", "value": "2007-09-27"}, {"name": "url-status", "value": "live"}]}, {"name": "cite book ", "values": [{"name": "title", "value": "Biochemistry"}, {"name": "last", "value": "Berg"}, {"name": "first", "value": "Jeremy M."}, {"name": "last2", "value": "Tymoczko"}, {"name": "first2", "value": "John L."}, {"name": "last3", "value": "Stryer"}, {"name": "first3", "value": "Lubert"}, {"name": "year", "value": "2007"}, {"name": "edition", "value": "6th"}, {"name": "publisher", "value": "W.&nbsp;H. Freeman"}, {"name": "location", "value": "New York, NY"}, {"name": "isbn", "value": "978-0-7167-8724-2"}, {"name": "page", "value": "413"}]}, {"name": "chem", "values": [{"name": "1", "value": "H"}, {"name": "2", "value": "2"}, {"name": "3", "value": "O"}]}, {"name": "pad", "values": [{"name": "1", "value": "1em"}]}, {"name": "chem", "values": [{"name": "1", "value": "H"}, {"name": "2", "value": "2"}, {"name": "3", "value": "O"}]}, {"name": "pad", "values": [{"name": "1", "value": "1em"}]}, {"name": "chem", "values": [{"name": "1", "value": "H"}, {"name": "2", "value": "2"}, {"name": "3", "value": "O"}]}, {"name": "chem", "values": [{"name": "1", "value": "H"}, {"name": "2", "value": "2"}, {"name": "3", "value": "O"}]}], "id": 3}, {"title": "Production from AMP and ADP", "paragraphs": "===Production, aerobic conditions===\nA typical intracellular [[concentration]] of ATP is hard to pin down, however, reports have shown there to be 1\u201310&nbsp;[[molarity|\u03bcM]] per gram of tissue in a variety of eukaryotes.<ref>{{cite journal| last1 = Beis |first1=I. |last2= Newsholme |first2=E.&nbsp;A. | date = October 1, 1975 | title= The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates | journal= Biochem. J. | volume=152 | pages= 23\u201332 | pmid=1212224 |pmc=1172435| issue = 1 | doi=10.1042/bj1520023}}\n</ref> The dephosphorylation of ATP and rephosphorylation of ADP and AMP occur repeatedly in the course of aerobic metabolism.\n\nATP can be produced by a number of distinct cellular processes; the three main pathways in [[eukaryote]]s are (1) [[glycolysis]], (2) the [[citric acid cycle]]/[[oxidative phosphorylation]], and (3) [[beta-oxidation]]. The overall process of oxidizing glucose to [[carbon dioxide]], the combination of pathways 1 and 2, is known as [[cellular respiration]], produces about 30 equivalents of ATP from each molecule of glucose.<ref name=Rich>{{cite journal |last=Rich |first=P.&nbsp;R. |title=The molecular machinery of Keilin's respiratory chain |journal=Biochem. Soc. Trans. |volume=31 |issue=6 |pages=1095\u20131105 |year=2003 |pmid=14641005 |doi=10.1042/BST0311095}}</ref>\n\nATP production by a non-[[photosynthetic]] aerobic eukaryote occurs mainly in the [[mitochondria]], which comprise nearly 25% of the volume of a typical cell.<ref name=\"Lodish\">{{cite book |last1=Lodish |first1=H. |last2=Berk |first2=A. |last3=Matsudaira |first3=P. |last4=Kaiser |first4=C.&nbsp;A. |last5=Krieger |first5=M. |last6=Scott |first6=M.&nbsp;P. |last7=Zipursky |first7=S.&nbsp;L. |last8=Darnell |first8=J. |title=Molecular Cell Biology |edition=5th |publisher=W.&nbsp;H. Freeman |location=New York, NY |isbn=978-0-7167-4366-8 |year=2004 |url-access=registration |url=https://archive.org/details/molecularcellbio00harv }}</ref>\n\n====Glycolysis====\n{{Main|Glycolysis}}\n\nIn glycolysis, glucose and glycerol are metabolized to [[pyruvate]]. Glycolysis generates two equivalents of ATP through [[substrate-level phosphorylation|substrate phosphorylation]] catalyzed by two enzymes, [[Phosphoglycerate kinase|PGK]] and [[pyruvate kinase]]. Two equivalents of [[NADH]] are also produced, which can be oxidized via the [[electron transport chain]] and result in the generation of additional ATP by [[ATP synthase]]. The pyruvate generated as an end-product of glycolysis is a substrate for the [[citric acid cycle|Krebs Cycle]].<ref name=Voet>{{cite book |last1=Voet |first1=D. |last2=Voet |first2=J.&nbsp;G. | year=2004 | title=Biochemistry |volume=1 |edition=3rd | publisher= Wiley |location=Hoboken, NJ | isbn = 978-0-471-19350-0}}</ref>\n\nGlycolysis is viewed as consisting of two phases with five steps each. Phase 1, \"the preparatory phase\", glucose is converted to 2 d-glyceraldehyde -3-phosphate (g3p). One ATP is invested in the Step 1, and another ATP is invested in Step 3. Steps 1 and 3 of glycolysis are referred to as \"Priming Steps\". In Phase 2, two equivalents of g3p are converted to two pyruvates . In Step 7, two ATP are produced. In addition, in Step 10, two further equivalents of ATP are produced. In Steps 7 and 10, ATP is generated from ADP. A net of two ATPs are formed in the glycolysis cycle. The glycolysis pathway is later associated with the Citric Acid Cycle which produces additional equivalents of ATP.\n\n=====Regulation=====\nIn glycolysis, [[hexokinase]] is directly inhibited by its product, glucose-6-phosphate, and [[pyruvate kinase]] is inhibited by ATP itself. The main control point for the glycolytic pathway is [[phosphofructokinase]] (PFK), which is allosterically inhibited by high concentrations of ATP and activated by high concentrations of AMP. The inhibition of PFK by ATP is unusual, since ATP is also a substrate in the reaction catalyzed by PFK; the active form of the enzyme is a [[tetramer protein|tetramer]] that exists in two conformations, only one of which binds the second substrate fructose-6-phosphate (F6P). The protein has two [[binding site]]s for ATP&nbsp;\u2013 the [[active site]] is accessible in either protein conformation, but ATP binding to the inhibitor site stabilizes the conformation that binds F6P poorly.<ref name=\"Voet\" /> A number of other small molecules can compensate for the ATP-induced shift in equilibrium conformation and reactivate PFK, including [[cyclic AMP]], [[ammonium]] ions, inorganic phosphate, and fructose-1,6- and -2,6-biphosphate.<ref name=\"Voet\" />\n\n====Citric acid cycle====\n{{Main|Citric acid cycle|oxidative phosphorylation}}\n\nIn the [[mitochondrion]], pyruvate is oxidized by the [[pyruvate dehydrogenase complex]] to the [[acetyl]] group, which is fully oxidized to [[carbon dioxide]] by the [[citric acid cycle]] (also known as the Krebs cycle). Every \"turn\" of the citric acid cycle produces two molecules of carbon dioxide, one equivalent of ATP [[guanosine triphosphate]] (GTP) through [[substrate-level phosphorylation]] catalyzed by [[succinyl-CoA synthetase]], as succinyl- CoA is converted to Succinate,  three equivalents of [[NADH]], and one equivalent of [[Flavin group|FADH<sub>2</sub>]]. NADH and FADH<sub>2</sub> are recycled (to NAD<sup>+</sup> and [[Flavin adenine dinucleotide|FAD]], respectively), generating additional ATP by [[oxidative phosphorylation]]. The oxidation of NADH results in the synthesis of 2\u20133 equivalents of ATP, and the oxidation of one FADH<sub>2</sub> yields between 1\u20132 equivalents of ATP.<ref name=\"Rich\" /> The majority of cellular ATP is generated by this process. Although the citric acid cycle itself does not involve molecular [[oxygen]], it is an obligately [[aerobic glycolysis|aerobic]] process because O<sub>2</sub> is used to recycle the NADH and FADH<sub>2</sub>. In the absence of oxygen, the citric acid cycle ceases.<ref name=\"Lodish\" />\n\nThe generation of ATP by the mitochondrion from cytosolic NADH relies on the [[malate-aspartate shuttle]] (and to a lesser extent, the [[glycerol-phosphate shuttle]]) because the inner mitochondrial membrane is impermeable to NADH and NAD<sup>+</sup>. Instead of transferring the generated NADH, a [[malate dehydrogenase]] enzyme converts [[oxaloacetate]] to [[malate]], which is translocated to the mitochondrial matrix. Another malate dehydrogenase-catalyzed reaction occurs in the opposite direction, producing oxaloacetate and NADH from the newly transported malate and the mitochondrion's interior store of NAD<sup>+</sup>. A [[transaminase]] converts the oxaloacetate to [[aspartate]] for transport back across the membrane and into the intermembrane space.<ref name=\"Lodish\" /><!--will put the antiporter/full cycle in the shuttle article-->\n\nIn oxidative phosphorylation, the passage of electrons from NADH and FADH<sub>2</sub> through the electron transport chain pumps [[proton]]s out of the mitochondrial matrix and into the intermembrane space. This pumping generates a [[proton motive force]] that is the net effect of a [[pH]] gradient and an [[electric potential]] gradient across the inner mitochondrial membrane. Flow of protons down this potential gradient&nbsp;\u2013 that is, from the intermembrane space to the matrix&nbsp;\u2013  yields ATP by [[ATP synthase]].<ref>{{cite journal |last1=Abrahams |first1=J. |last2=Leslie |first2=A. |last3=Lutter |first3=R. |last4=Walker |first4=J. | title = Structure at 2.8&nbsp;\u00c5 resolution of F1-ATPase from bovine heart mitochondria | journal = Nature | volume = 370 | issue = 6491 | pages = 621\u2013628 | year = 1994 |pmid=8065448 | doi = 10.1038/370621a0 }}</ref> Three ATP are produced per turn.\n\nAlthough oxygen consumption appears fundamental for the maintenance of the [[proton motive force]], in the event of oxygen shortage ([[Hypoxia (medical)|hypoxia]]), intracellular acidosis (mediated by enhanced glycolytic rates and ATP hydrolysis), contributes to mitochondrial membrane potential and directly drives ATP synthesis<ref>{{cite journal | pmid = 30713504 | volume=9, 1914 | title=Acidosis Maintains the Function of Brain Mitochondria in Hypoxia-Tolerant Triplefin Fish: A Strategy to Survive Acute Hypoxic Exposure? | pmc=6346031 | date=January 2019 | journal=Front Physiol | doi=10.3389/fphys.2018.01941 | last1 = Devaux | first1 = JBL | last2 = Hedges | first2 = CP | last3 = Hickey | first3 = AJR}}</ref>..  \n\nMost of the ATP synthesized in the mitochondria will be used for cellular processes in the cytosol; thus it must be exported from its site of synthesis in the mitochondrial matrix. ATP outward movement is favored by the membrane's electrochemical potential because the cytosol has a relatively positive charge compared to the relatively negative matrix. For every ATP transported out, it costs 1 H<sup>+</sup>. One ATP costs about 3  H<sup>+</sup>. Therefore, making and exporting one ATP requires  4H<sup>+.</sup> The inner membrane contains an [[antiporter]], the [[adenosine diphosphate|ADP]]/ATP translocase, which is an [[integral membrane protein]] used to exchange newly synthesized ATP in the matrix for [[adenosine diphosphate|ADP]] in the intermembrane space.<ref name=\"Brandolin\">{{cite journal |last1=Dahout-Gonzalez |first1=C. |last2=Nury |first2=H. |last3=Tr\u00e9z\u00e9guet |first3=V. |last4=Lauquin |first4=G. |last5=Pebay-Peyroula |first5=E. |last6=Brandolin |first6=G. | title = Molecular, functional, and pathological aspects of the mitochondrial ADP/ATP carrier | journal = Physiology | volume = 21 | pages = 242\u2013249 | year = 2006| pmid = 16868313 | doi=10.1152/physiol.00005.2006 | issue = 4 }}</ref> This translocase is driven by the membrane potential, as it results in the movement of about 4 negative charges out of the mitochondrial membrane in exchange for 3 negative charges moved inside. However, it is also necessary to transport phosphate into the mitochondrion; the phosphate carrier moves a proton in with each phosphate, partially dissipating the proton gradient. After completing glycolysis, the Citric Acid Cycle, electrons transport chain, and oxidative phosphorylation, approximately 30\u201338 ATP are produced per glucose.\n\n=====Regulation=====\nThe citric acid cycle is regulated mainly by the availability of key substrates, particularly the ratio of NAD<sup>+</sup> to NADH and the concentrations of [[calcium]], inorganic phosphate, ATP, [[adenosine diphosphate|ADP]], and AMP. [[Citrate]]&nbsp;\u2013 the ion that gives its name to the cycle&nbsp;\u2013 is a feedback inhibitor of [[citrate synthase]] and also inhibits PFK, providing a direct link between the regulation of the citric acid cycle and glycolysis.<ref name=\"Voet\" />\n\n====Beta oxidation====\n{{Main|Beta-oxidation}}\nIn the presence of air and various cofactors and enzymes, fatty acids are converted to [[acetyl-CoA]]. The pathway is called [[beta-oxidation]]. Each cycle of beta-oxidation shortens the fatty acid chain by two carbon atoms and produces one equivalent each of acetyl-CoA, NADH, and FADH<sub>2</sub>. The acetyl-CoA is metabolized by the citric acid cycle to generate ATP, while the NADH and FADH<sub>2</sub> are used  by oxidative phosphorylation to generate ATP.  Dozens of ATP equivalents are generated by the beta-oxidation of a single long acyl chain.<ref>{{cite journal |last1=Ronnett |first1=G. |last2=Kim |first2=E. |last3=Landree |first3=L. |last4=Tu |first4=Y. | title = Fatty acid metabolism as a target for obesity treatment | journal = Physiol. Behav. | volume = 85 | issue = 1 | pages = 25\u201335 | year = 2005 | pmid = 15878185 | doi=10.1016/j.physbeh.2005.04.014 }}</ref>\n\n=====Regulation=====\nIn oxidative phosphorylation, the key control point is the reaction catalyzed by [[cytochrome c oxidase]], which is regulated by the availability of its substrate&nbsp;\u2013 the reduced form of [[cytochrome c]]. The amount of reduced cytochrome c available is directly related to the amounts of other substrates:\n\n:<math chem>\n\\frac12 \\ce{NADH} + \\ce{cyt}\\ \\ce{c_{ox}} + \\ce{ADP} + \\ce{P_i} \\rightleftharpoons\n\\frac12 \\ce{NAD^+} + \\ce{cyt}\\ \\ce{c_{red}} + \\ce{ATP}\n</math>\n\nwhich directly implies this equation:\n\n:<math>\n\\frac{[\\mathrm{cyt~c_{red}}]}{[\\mathrm{cyt~c_{ox}}]} = \\left(\\frac{[\\mathrm{NADH}]}{[\\mathrm{NAD}]^{+}}\\right)^{\\frac{1}{2}}\\left(\\frac{[\\mathrm{ADP}] [\\mathrm{P_i}]}{[\\mathrm{ATP}]}\\right)K_\\mathrm{eq}\n</math>\n\nThus, a high ratio of [NADH] to [NAD<sup>+</sup>] or a high ratio of [ADP][P<sub>i</sub>] to [ATP] imply a high amount of reduced cytochrome c and a high level of cytochrome c oxidase activity.<ref name=\"Voet\" /> An additional level of regulation is introduced by the transport rates of ATP and NADH between the mitochondrial matrix and the cytoplasm.<ref name=\"Brandolin\" />\n\n====Ketosis====\n{{Main|Ketone bodies}}\n\nKetone bodies can be used as fuels, yielding 22 ATP and 2 [[Guanosine triphosphate|GTP]] molecules per acetoacetate molecule when oxidized in the mitochondria. Ketone bodies are transported from the [[liver]] to other tissues, where [[acetoacetate]] and [[beta-Hydroxybutyric acid|''beta''-hydroxybutyrate]] can be reconverted to [[acetyl-CoA]] to produce reducing equivalents (NADH and FADH<sub>2</sub>), via the [[citric acid cycle]]. Ketone bodies cannot be used as fuel by the liver, because the liver lacks the enzyme \u03b2-ketoacyl-CoA transferase, also called thiophorase.  [[Acetoacetate]] in low concentrations is taken up by the liver and undergoes detoxification through the methylglyoxal pathway which ends with lactate. [[Acetoacetate]] in high concentrations is absorbed by cells other than those in the liver and enters a different pathway via [[1,2-propanediol]].  Though the pathway follows a different series of steps requiring ATP, 1,2-propanediol can be turned into pyruvate.<ref name=\"Environmental Protection Agency; TOXICOLOGICAL REVIEW OF ACETONE (CAS No. 67-64-1)\">{{Cite web| url=http://www.epa.gov/iris/toxreviews/0128tr.pdf| title=Integrated Risk Information System| date=2013-03-15| access-date=2019-02-01| archive-url=https://web.archive.org/web/20150924074331/http://www.epa.gov/iris/toxreviews/0128tr.pdf| archive-date=2015-09-24| url-status=live}}</ref>\n\n===Production, anaerobic conditions===\n[[fermentation (biochemistry)|Fermentation]] is the metabolism of organic compounds in the absence of air. It involves [[substrate-level phosphorylation]] in the absence of a respiratory [[electron transport chain]]. The equation for the oxidation of glucose to [[lactic acid]] is:\n: {{chem|C|6|H|12|O|6}} \u2192 2&nbsp;{{chem|CH|3|CH(OH)COOH}} + 2&nbsp;ATP\n\n[[Anaerobic respiration]] is respiration in the absence of {{chem|link=oxygen|O|2}}. Prokaryotes can utilize a variety of electron acceptors. These include [[nitrate]], [[sulfate]], and carbon dioxide.\n\n===ATP replenishment by nucleoside diphosphate kinases===\nATP can also be synthesized through several so-called \"replenishment\" reactions catalyzed by the enzyme families of [[nucleoside diphosphate kinase]]s (NDKs), which use other nucleoside triphosphates as a high-energy phosphate donor, and the [[ATP:guanido phosphotransferase family|ATP:guanido-phosphotransferase]] family.\n\n===ATP production during photosynthesis===\nIn plants, ATP is synthesized in the [[thylakoid membrane]] of the [[chloroplast]].  The process is called photophosphorylation. The \"machinery\" is similar to that in mitochondria except that light energy is used to pump protons across a membrane to produce a proton-motive force. ATP synthase then ensues exactly as in oxidative phosphorylation.<ref>{{cite journal | last = Allen | first = J. | title = Photosynthesis of ATP-electrons, proton pumps, rotors, and poise | journal = Cell | volume = 110 | issue = 3 | pages = 273\u2013276 | year = 2002 | pmid = 12176312 | doi = 10.1016/S0092-8674(02)00870-X }}</ref> Some of the ATP produced in the chloroplasts is consumed in the [[Calvin cycle]], which produces [[triose]] sugars.\n\n===ATP recycling===\nThe total quantity of ATP in the human body is about 0.2&nbsp;[[Mole (unit)|mole]]s. The majority of ATP is recycled from [[adenosine diphosphate|ADP]] by the aforementioned processes. Thus, at any given time, the total amount of ATP + [[adenosine diphosphate|ADP]] remains fairly constant.\n\nThe energy used by human cells requires the [[hydrolysis]] of 100 to 150&nbsp;moles of ATP daily, which is around 50 to 75&nbsp;kg. A human will typically use up his or her body weight of ATP over the course of the day. Each equivalent of ATP is recycled 500\u2013750 times during a single day ({{nowrap|100 / 0.2 {{=}} 500}}).{{Citation needed|date=January 2020}}\n\n[[Image:Rossmann-fold-1g5q.png|thumb|An example of the Rossmann fold, a [[structural domain]] of a [[decarboxylase]] enzyme from the bacterium ''[[Staphylococcus epidermidis]]'' ({{PDB|1G5Q}}) with a bound [[flavin mononucleotide]] cofactor.]]\n\n", "attributes": [{"name": "cite journal", "values": [{"name": "last1", "value": "Beis"}, {"name": "first1", "value": "I."}, {"name": "last2", "value": "Newsholme"}, {"name": "first2", "value": "E.&nbsp;A."}, {"name": "date", "value": "October 1, 1975"}, {"name": "title", "value": "The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates"}, {"name": "journal", "value": "Biochem. J."}, {"name": "volume", "value": "152"}, {"name": "pages", "value": "23\u201332"}, {"name": "pmid", "value": "1212224"}, {"name": "pmc", "value": "1172435"}, {"name": "issue", "value": "1"}, {"name": "doi", "value": "10.1042/bj1520023"}]}, {"name": "cite journal ", "values": [{"name": "last", "value": "Rich"}, {"name": "first", "value": "P.&nbsp;R."}, {"name": "title", "value": "The molecular machinery of Keilin's respiratory chain"}, {"name": "journal", "value": "Biochem. Soc. Trans."}, {"name": "volume", "value": "31"}, {"name": "issue", "value": "6"}, {"name": "pages", "value": "1095\u20131105"}, {"name": "year", "value": "2003"}, {"name": "pmid", "value": "14641005"}, {"name": "doi", "value": "10.1042/BST0311095"}]}, {"name": "cite book ", "values": [{"name": "last1", "value": "Lodish"}, {"name": "first1", "value": "H."}, {"name": "last2", "value": "Berk"}, {"name": "first2", "value": "A."}, {"name": "last3", "value": "Matsudaira"}, {"name": "first3", "value": "P."}, {"name": "last4", "value": "Kaiser"}, {"name": "first4", "value": "C.&nbsp;A."}, {"name": "last5", "value": "Krieger"}, {"name": "first5", "value": "M."}, {"name": "last6", "value": "Scott"}, {"name": "first6", "value": "M.&nbsp;P."}, {"name": "last7", "value": "Zipursky"}, {"name": "first7", "value": "S.&nbsp;L."}, {"name": "last8", "value": "Darnell"}, {"name": "first8", "value": "J."}, {"name": "title", "value": "Molecular Cell Biology"}, {"name": "edition", "value": "5th"}, {"name": "publisher", "value": "W.&nbsp;H. Freeman"}, {"name": "location", "value": "New York, NY"}, {"name": "isbn", "value": "978-0-7167-4366-8"}, {"name": "year", "value": "2004"}, {"name": "url-access", "value": "registration"}, {"name": "url", "value": "https://archive.org/details/molecularcellbio00harv"}]}, {"name": "Main", "values": [{"name": "1", "value": "Glycolysis"}]}, {"name": "cite book ", "values": [{"name": "last1", "value": "Voet"}, {"name": "first1", "value": "D."}, {"name": "last2", "value": "Voet"}, {"name": "first2", "value": "J.&nbsp;G."}, {"name": "year", "value": "2004"}, {"name": "title", "value": "Biochemistry"}, {"name": "volume", "value": "1"}, {"name": "edition", "value": "3rd"}, {"name": "publisher", "value": "Wiley"}, {"name": "location", "value": "Hoboken, NJ"}, {"name": "isbn", "value": "978-0-471-19350-0"}]}, {"name": "Main", "values": [{"name": "1", "value": "Citric acid cycle"}, {"name": "2", "value": "oxidative phosphorylation"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Abrahams"}, {"name": "first1", "value": "J."}, {"name": "last2", "value": "Leslie"}, {"name": "first2", "value": "A."}, {"name": "last3", "value": "Lutter"}, {"name": "first3", "value": "R."}, {"name": "last4", "value": "Walker"}, {"name": "first4", "value": "J."}, {"name": "title", "value": "Structure at 2.8&nbsp;\u00c5 resolution of F1-ATPase from bovine heart mitochondria"}, {"name": "journal", "value": "Nature"}, {"name": "volume", "value": "370"}, {"name": "issue", "value": "6491"}, {"name": "pages", "value": "621\u2013628"}, {"name": "year", "value": "1994"}, {"name": "pmid", "value": "8065448"}, {"name": "doi", "value": "10.1038/370621a0"}]}, {"name": "cite journal ", "values": [{"name": "pmid", "value": "30713504"}, {"name": "volume", "value": "9, 1914"}, {"name": "title", "value": "Acidosis Maintains the Function of Brain Mitochondria in Hypoxia-Tolerant Triplefin Fish: A Strategy to Survive Acute Hypoxic Exposure?"}, {"name": "pmc", "value": "6346031"}, {"name": "date", "value": "January 2019"}, {"name": "journal", "value": "Front Physiol"}, {"name": "doi", "value": "10.3389/fphys.2018.01941"}, {"name": "last1", "value": "Devaux"}, {"name": "first1", "value": "JBL"}, {"name": "last2", "value": "Hedges"}, {"name": "first2", "value": "CP"}, {"name": "last3", "value": "Hickey"}, {"name": "first3", "value": "AJR"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Dahout-Gonzalez"}, {"name": "first1", "value": "C."}, {"name": "last2", "value": "Nury"}, {"name": "first2", "value": "H."}, {"name": "last3", "value": "Tr\u00e9z\u00e9guet"}, {"name": "first3", "value": "V."}, {"name": "last4", "value": "Lauquin"}, {"name": "first4", "value": "G."}, {"name": "last5", "value": "Pebay-Peyroula"}, {"name": "first5", "value": "E."}, {"name": "last6", "value": "Brandolin"}, {"name": "first6", "value": "G."}, {"name": "title", "value": "Molecular, functional, and pathological aspects of the mitochondrial ADP/ATP carrier"}, {"name": "journal", "value": "Physiology"}, {"name": "volume", "value": "21"}, {"name": "pages", "value": "242\u2013249"}, {"name": "year", "value": "2006"}, {"name": "pmid", "value": "16868313"}, {"name": "doi", "value": "10.1152/physiol.00005.2006"}, {"name": "issue", "value": "4"}]}, {"name": "Main", "values": [{"name": "1", "value": "Beta-oxidation"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Ronnett"}, {"name": "first1", "value": "G."}, {"name": "last2", "value": "Kim"}, {"name": "first2", "value": "E."}, {"name": "last3", "value": "Landree"}, {"name": "first3", "value": "L."}, {"name": "last4", "value": "Tu"}, {"name": "first4", "value": "Y."}, {"name": "title", "value": "Fatty acid metabolism as a target for obesity treatment"}, {"name": "journal", "value": "Physiol. Behav."}, {"name": "volume", "value": "85"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "25\u201335"}, {"name": "year", "value": "2005"}, {"name": "pmid", "value": "15878185"}, {"name": "doi", "value": "10.1016/j.physbeh.2005.04.014"}]}, {"name": "Main", "values": [{"name": "1", "value": "Ketone bodies"}]}, {"name": "Cite web", "values": [{"name": "url", "value": "http://www.epa.gov/iris/toxreviews/0128tr.pdf"}, {"name": "title", "value": "Integrated Risk Information System"}, {"name": "date", "value": "2013-03-15"}, {"name": "access-date", "value": "2019-02-01"}, {"name": "archive-url", "value": "https://web.archive.org/web/20150924074331/http://www.epa.gov/iris/toxreviews/0128tr.pdf"}, {"name": "archive-date", "value": "2015-09-24"}, {"name": "url-status", "value": "live"}]}, {"name": "chem", "values": [{"name": "1", "value": "C"}, {"name": "2", "value": "6"}, {"name": "3", "value": "H"}, {"name": "4", "value": "12"}, {"name": "5", "value": "O"}, {"name": "6", "value": "6"}]}, {"name": "chem", "values": [{"name": "1", "value": "CH"}, {"name": "2", "value": "3"}, {"name": "3", "value": "CH(OH)COOH"}]}, {"name": "chem", "values": [{"name": "link", "value": "oxygen"}, {"name": "1", "value": "O"}, {"name": "2", "value": "2"}]}, {"name": "cite journal ", "values": [{"name": "last", "value": "Allen"}, {"name": "first", "value": "J."}, {"name": "title", "value": "Photosynthesis of ATP-electrons, proton pumps, rotors, and poise"}, {"name": "journal", "value": "Cell"}, {"name": "volume", "value": "110"}, {"name": "issue", "value": "3"}, {"name": "pages", "value": "273\u2013276"}, {"name": "year", "value": "2002"}, {"name": "pmid", "value": "12176312"}, {"name": "doi", "value": "10.1016/S0092-8674(02)00870-X"}]}, {"name": "nowrap", "values": [{"name": "1", "value": "100 / 0.2 {{=}} 500"}]}, {"name": "Citation needed", "values": [{"name": "date", "value": "January 2020"}]}, {"name": "PDB", "values": [{"name": "1", "value": "1G5Q"}]}], "id": 4}, {"title": "Production, aerobic conditions", "paragraphs": "A typical intracellular [[concentration]] of ATP is hard to pin down, however, reports have shown there to be 1\u201310&nbsp;[[molarity|\u03bcM]] per gram of tissue in a variety of eukaryotes.<ref>{{cite journal| last1 = Beis |first1=I. |last2= Newsholme |first2=E.&nbsp;A. | date = October 1, 1975 | title= The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates | journal= Biochem. J. | volume=152 | pages= 23\u201332 | pmid=1212224 |pmc=1172435| issue = 1 | doi=10.1042/bj1520023}}\n</ref> The dephosphorylation of ATP and rephosphorylation of ADP and AMP occur repeatedly in the course of aerobic metabolism.\n\nATP can be produced by a number of distinct cellular processes; the three main pathways in [[eukaryote]]s are (1) [[glycolysis]], (2) the [[citric acid cycle]]/[[oxidative phosphorylation]], and (3) [[beta-oxidation]]. The overall process of oxidizing glucose to [[carbon dioxide]], the combination of pathways 1 and 2, is known as [[cellular respiration]], produces about 30 equivalents of ATP from each molecule of glucose.<ref name=Rich>{{cite journal |last=Rich |first=P.&nbsp;R. |title=The molecular machinery of Keilin's respiratory chain |journal=Biochem. Soc. Trans. |volume=31 |issue=6 |pages=1095\u20131105 |year=2003 |pmid=14641005 |doi=10.1042/BST0311095}}</ref>\n\nATP production by a non-[[photosynthetic]] aerobic eukaryote occurs mainly in the [[mitochondria]], which comprise nearly 25% of the volume of a typical cell.<ref name=\"Lodish\">{{cite book |last1=Lodish |first1=H. |last2=Berk |first2=A. |last3=Matsudaira |first3=P. |last4=Kaiser |first4=C.&nbsp;A. |last5=Krieger |first5=M. |last6=Scott |first6=M.&nbsp;P. |last7=Zipursky |first7=S.&nbsp;L. |last8=Darnell |first8=J. |title=Molecular Cell Biology |edition=5th |publisher=W.&nbsp;H. Freeman |location=New York, NY |isbn=978-0-7167-4366-8 |year=2004 |url-access=registration |url=https://archive.org/details/molecularcellbio00harv }}</ref>\n\n====Glycolysis====\n{{Main|Glycolysis}}\n\nIn glycolysis, glucose and glycerol are metabolized to [[pyruvate]]. Glycolysis generates two equivalents of ATP through [[substrate-level phosphorylation|substrate phosphorylation]] catalyzed by two enzymes, [[Phosphoglycerate kinase|PGK]] and [[pyruvate kinase]]. Two equivalents of [[NADH]] are also produced, which can be oxidized via the [[electron transport chain]] and result in the generation of additional ATP by [[ATP synthase]]. The pyruvate generated as an end-product of glycolysis is a substrate for the [[citric acid cycle|Krebs Cycle]].<ref name=Voet>{{cite book |last1=Voet |first1=D. |last2=Voet |first2=J.&nbsp;G. | year=2004 | title=Biochemistry |volume=1 |edition=3rd | publisher= Wiley |location=Hoboken, NJ | isbn = 978-0-471-19350-0}}</ref>\n\nGlycolysis is viewed as consisting of two phases with five steps each. Phase 1, \"the preparatory phase\", glucose is converted to 2 d-glyceraldehyde -3-phosphate (g3p). One ATP is invested in the Step 1, and another ATP is invested in Step 3. Steps 1 and 3 of glycolysis are referred to as \"Priming Steps\". In Phase 2, two equivalents of g3p are converted to two pyruvates . In Step 7, two ATP are produced. In addition, in Step 10, two further equivalents of ATP are produced. In Steps 7 and 10, ATP is generated from ADP. A net of two ATPs are formed in the glycolysis cycle. The glycolysis pathway is later associated with the Citric Acid Cycle which produces additional equivalents of ATP.\n\n=====Regulation=====\nIn glycolysis, [[hexokinase]] is directly inhibited by its product, glucose-6-phosphate, and [[pyruvate kinase]] is inhibited by ATP itself. The main control point for the glycolytic pathway is [[phosphofructokinase]] (PFK), which is allosterically inhibited by high concentrations of ATP and activated by high concentrations of AMP. The inhibition of PFK by ATP is unusual, since ATP is also a substrate in the reaction catalyzed by PFK; the active form of the enzyme is a [[tetramer protein|tetramer]] that exists in two conformations, only one of which binds the second substrate fructose-6-phosphate (F6P). The protein has two [[binding site]]s for ATP&nbsp;\u2013 the [[active site]] is accessible in either protein conformation, but ATP binding to the inhibitor site stabilizes the conformation that binds F6P poorly.<ref name=\"Voet\" /> A number of other small molecules can compensate for the ATP-induced shift in equilibrium conformation and reactivate PFK, including [[cyclic AMP]], [[ammonium]] ions, inorganic phosphate, and fructose-1,6- and -2,6-biphosphate.<ref name=\"Voet\" />\n\n====Citric acid cycle====\n{{Main|Citric acid cycle|oxidative phosphorylation}}\n\nIn the [[mitochondrion]], pyruvate is oxidized by the [[pyruvate dehydrogenase complex]] to the [[acetyl]] group, which is fully oxidized to [[carbon dioxide]] by the [[citric acid cycle]] (also known as the Krebs cycle). Every \"turn\" of the citric acid cycle produces two molecules of carbon dioxide, one equivalent of ATP [[guanosine triphosphate]] (GTP) through [[substrate-level phosphorylation]] catalyzed by [[succinyl-CoA synthetase]], as succinyl- CoA is converted to Succinate,  three equivalents of [[NADH]], and one equivalent of [[Flavin group|FADH<sub>2</sub>]]. NADH and FADH<sub>2</sub> are recycled (to NAD<sup>+</sup> and [[Flavin adenine dinucleotide|FAD]], respectively), generating additional ATP by [[oxidative phosphorylation]]. The oxidation of NADH results in the synthesis of 2\u20133 equivalents of ATP, and the oxidation of one FADH<sub>2</sub> yields between 1\u20132 equivalents of ATP.<ref name=\"Rich\" /> The majority of cellular ATP is generated by this process. Although the citric acid cycle itself does not involve molecular [[oxygen]], it is an obligately [[aerobic glycolysis|aerobic]] process because O<sub>2</sub> is used to recycle the NADH and FADH<sub>2</sub>. In the absence of oxygen, the citric acid cycle ceases.<ref name=\"Lodish\" />\n\nThe generation of ATP by the mitochondrion from cytosolic NADH relies on the [[malate-aspartate shuttle]] (and to a lesser extent, the [[glycerol-phosphate shuttle]]) because the inner mitochondrial membrane is impermeable to NADH and NAD<sup>+</sup>. Instead of transferring the generated NADH, a [[malate dehydrogenase]] enzyme converts [[oxaloacetate]] to [[malate]], which is translocated to the mitochondrial matrix. Another malate dehydrogenase-catalyzed reaction occurs in the opposite direction, producing oxaloacetate and NADH from the newly transported malate and the mitochondrion's interior store of NAD<sup>+</sup>. A [[transaminase]] converts the oxaloacetate to [[aspartate]] for transport back across the membrane and into the intermembrane space.<ref name=\"Lodish\" /><!--will put the antiporter/full cycle in the shuttle article-->\n\nIn oxidative phosphorylation, the passage of electrons from NADH and FADH<sub>2</sub> through the electron transport chain pumps [[proton]]s out of the mitochondrial matrix and into the intermembrane space. This pumping generates a [[proton motive force]] that is the net effect of a [[pH]] gradient and an [[electric potential]] gradient across the inner mitochondrial membrane. Flow of protons down this potential gradient&nbsp;\u2013 that is, from the intermembrane space to the matrix&nbsp;\u2013  yields ATP by [[ATP synthase]].<ref>{{cite journal |last1=Abrahams |first1=J. |last2=Leslie |first2=A. |last3=Lutter |first3=R. |last4=Walker |first4=J. | title = Structure at 2.8&nbsp;\u00c5 resolution of F1-ATPase from bovine heart mitochondria | journal = Nature | volume = 370 | issue = 6491 | pages = 621\u2013628 | year = 1994 |pmid=8065448 | doi = 10.1038/370621a0 }}</ref> Three ATP are produced per turn.\n\nAlthough oxygen consumption appears fundamental for the maintenance of the [[proton motive force]], in the event of oxygen shortage ([[Hypoxia (medical)|hypoxia]]), intracellular acidosis (mediated by enhanced glycolytic rates and ATP hydrolysis), contributes to mitochondrial membrane potential and directly drives ATP synthesis<ref>{{cite journal | pmid = 30713504 | volume=9, 1914 | title=Acidosis Maintains the Function of Brain Mitochondria in Hypoxia-Tolerant Triplefin Fish: A Strategy to Survive Acute Hypoxic Exposure? | pmc=6346031 | date=January 2019 | journal=Front Physiol | doi=10.3389/fphys.2018.01941 | last1 = Devaux | first1 = JBL | last2 = Hedges | first2 = CP | last3 = Hickey | first3 = AJR}}</ref>..  \n\nMost of the ATP synthesized in the mitochondria will be used for cellular processes in the cytosol; thus it must be exported from its site of synthesis in the mitochondrial matrix. ATP outward movement is favored by the membrane's electrochemical potential because the cytosol has a relatively positive charge compared to the relatively negative matrix. For every ATP transported out, it costs 1 H<sup>+</sup>. One ATP costs about 3  H<sup>+</sup>. Therefore, making and exporting one ATP requires  4H<sup>+.</sup> The inner membrane contains an [[antiporter]], the [[adenosine diphosphate|ADP]]/ATP translocase, which is an [[integral membrane protein]] used to exchange newly synthesized ATP in the matrix for [[adenosine diphosphate|ADP]] in the intermembrane space.<ref name=\"Brandolin\">{{cite journal |last1=Dahout-Gonzalez |first1=C. |last2=Nury |first2=H. |last3=Tr\u00e9z\u00e9guet |first3=V. |last4=Lauquin |first4=G. |last5=Pebay-Peyroula |first5=E. |last6=Brandolin |first6=G. | title = Molecular, functional, and pathological aspects of the mitochondrial ADP/ATP carrier | journal = Physiology | volume = 21 | pages = 242\u2013249 | year = 2006| pmid = 16868313 | doi=10.1152/physiol.00005.2006 | issue = 4 }}</ref> This translocase is driven by the membrane potential, as it results in the movement of about 4 negative charges out of the mitochondrial membrane in exchange for 3 negative charges moved inside. However, it is also necessary to transport phosphate into the mitochondrion; the phosphate carrier moves a proton in with each phosphate, partially dissipating the proton gradient. After completing glycolysis, the Citric Acid Cycle, electrons transport chain, and oxidative phosphorylation, approximately 30\u201338 ATP are produced per glucose.\n\n=====Regulation=====\nThe citric acid cycle is regulated mainly by the availability of key substrates, particularly the ratio of NAD<sup>+</sup> to NADH and the concentrations of [[calcium]], inorganic phosphate, ATP, [[adenosine diphosphate|ADP]], and AMP. [[Citrate]]&nbsp;\u2013 the ion that gives its name to the cycle&nbsp;\u2013 is a feedback inhibitor of [[citrate synthase]] and also inhibits PFK, providing a direct link between the regulation of the citric acid cycle and glycolysis.<ref name=\"Voet\" />\n\n====Beta oxidation====\n{{Main|Beta-oxidation}}\nIn the presence of air and various cofactors and enzymes, fatty acids are converted to [[acetyl-CoA]]. The pathway is called [[beta-oxidation]]. Each cycle of beta-oxidation shortens the fatty acid chain by two carbon atoms and produces one equivalent each of acetyl-CoA, NADH, and FADH<sub>2</sub>. The acetyl-CoA is metabolized by the citric acid cycle to generate ATP, while the NADH and FADH<sub>2</sub> are used  by oxidative phosphorylation to generate ATP.  Dozens of ATP equivalents are generated by the beta-oxidation of a single long acyl chain.<ref>{{cite journal |last1=Ronnett |first1=G. |last2=Kim |first2=E. |last3=Landree |first3=L. |last4=Tu |first4=Y. | title = Fatty acid metabolism as a target for obesity treatment | journal = Physiol. Behav. | volume = 85 | issue = 1 | pages = 25\u201335 | year = 2005 | pmid = 15878185 | doi=10.1016/j.physbeh.2005.04.014 }}</ref>\n\n=====Regulation=====\nIn oxidative phosphorylation, the key control point is the reaction catalyzed by [[cytochrome c oxidase]], which is regulated by the availability of its substrate&nbsp;\u2013 the reduced form of [[cytochrome c]]. The amount of reduced cytochrome c available is directly related to the amounts of other substrates:\n\n:<math chem>\n\\frac12 \\ce{NADH} + \\ce{cyt}\\ \\ce{c_{ox}} + \\ce{ADP} + \\ce{P_i} \\rightleftharpoons\n\\frac12 \\ce{NAD^+} + \\ce{cyt}\\ \\ce{c_{red}} + \\ce{ATP}\n</math>\n\nwhich directly implies this equation:\n\n:<math>\n\\frac{[\\mathrm{cyt~c_{red}}]}{[\\mathrm{cyt~c_{ox}}]} = \\left(\\frac{[\\mathrm{NADH}]}{[\\mathrm{NAD}]^{+}}\\right)^{\\frac{1}{2}}\\left(\\frac{[\\mathrm{ADP}] [\\mathrm{P_i}]}{[\\mathrm{ATP}]}\\right)K_\\mathrm{eq}\n</math>\n\nThus, a high ratio of [NADH] to [NAD<sup>+</sup>] or a high ratio of [ADP][P<sub>i</sub>] to [ATP] imply a high amount of reduced cytochrome c and a high level of cytochrome c oxidase activity.<ref name=\"Voet\" /> An additional level of regulation is introduced by the transport rates of ATP and NADH between the mitochondrial matrix and the cytoplasm.<ref name=\"Brandolin\" />\n\n====Ketosis====\n{{Main|Ketone bodies}}\n\nKetone bodies can be used as fuels, yielding 22 ATP and 2 [[Guanosine triphosphate|GTP]] molecules per acetoacetate molecule when oxidized in the mitochondria. Ketone bodies are transported from the [[liver]] to other tissues, where [[acetoacetate]] and [[beta-Hydroxybutyric acid|''beta''-hydroxybutyrate]] can be reconverted to [[acetyl-CoA]] to produce reducing equivalents (NADH and FADH<sub>2</sub>), via the [[citric acid cycle]]. Ketone bodies cannot be used as fuel by the liver, because the liver lacks the enzyme \u03b2-ketoacyl-CoA transferase, also called thiophorase.  [[Acetoacetate]] in low concentrations is taken up by the liver and undergoes detoxification through the methylglyoxal pathway which ends with lactate. [[Acetoacetate]] in high concentrations is absorbed by cells other than those in the liver and enters a different pathway via [[1,2-propanediol]].  Though the pathway follows a different series of steps requiring ATP, 1,2-propanediol can be turned into pyruvate.<ref name=\"Environmental Protection Agency; TOXICOLOGICAL REVIEW OF ACETONE (CAS No. 67-64-1)\">{{Cite web| url=http://www.epa.gov/iris/toxreviews/0128tr.pdf| title=Integrated Risk Information System| date=2013-03-15| access-date=2019-02-01| archive-url=https://web.archive.org/web/20150924074331/http://www.epa.gov/iris/toxreviews/0128tr.pdf| archive-date=2015-09-24| url-status=live}}</ref>\n\n", "attributes": [{"name": "cite journal", "values": [{"name": "last1", "value": "Beis"}, {"name": "first1", "value": "I."}, {"name": "last2", "value": "Newsholme"}, {"name": "first2", "value": "E.&nbsp;A."}, {"name": "date", "value": "October 1, 1975"}, {"name": "title", "value": "The contents of adenine nucleotides, phosphagens and some glycolytic intermediates in resting muscles from vertebrates and invertebrates"}, {"name": "journal", "value": "Biochem. J."}, {"name": "volume", "value": "152"}, {"name": "pages", "value": "23\u201332"}, {"name": "pmid", "value": "1212224"}, {"name": "pmc", "value": "1172435"}, {"name": "issue", "value": "1"}, {"name": "doi", "value": "10.1042/bj1520023"}]}, {"name": "cite journal ", "values": [{"name": "last", "value": "Rich"}, {"name": "first", "value": "P.&nbsp;R."}, {"name": "title", "value": "The molecular machinery of Keilin's respiratory chain"}, {"name": "journal", "value": "Biochem. Soc. Trans."}, {"name": "volume", "value": "31"}, {"name": "issue", "value": "6"}, {"name": "pages", "value": "1095\u20131105"}, {"name": "year", "value": "2003"}, {"name": "pmid", "value": "14641005"}, {"name": "doi", "value": "10.1042/BST0311095"}]}, {"name": "cite book ", "values": [{"name": "last1", "value": "Lodish"}, {"name": "first1", "value": "H."}, {"name": "last2", "value": "Berk"}, {"name": "first2", "value": "A."}, {"name": "last3", "value": "Matsudaira"}, {"name": "first3", "value": "P."}, {"name": "last4", "value": "Kaiser"}, {"name": "first4", "value": "C.&nbsp;A."}, {"name": "last5", "value": "Krieger"}, {"name": "first5", "value": "M."}, {"name": "last6", "value": "Scott"}, {"name": "first6", "value": "M.&nbsp;P."}, {"name": "last7", "value": "Zipursky"}, {"name": "first7", "value": "S.&nbsp;L."}, {"name": "last8", "value": "Darnell"}, {"name": "first8", "value": "J."}, {"name": "title", "value": "Molecular Cell Biology"}, {"name": "edition", "value": "5th"}, {"name": "publisher", "value": "W.&nbsp;H. Freeman"}, {"name": "location", "value": "New York, NY"}, {"name": "isbn", "value": "978-0-7167-4366-8"}, {"name": "year", "value": "2004"}, {"name": "url-access", "value": "registration"}, {"name": "url", "value": "https://archive.org/details/molecularcellbio00harv"}]}, {"name": "Main", "values": [{"name": "1", "value": "Glycolysis"}]}, {"name": "cite book ", "values": [{"name": "last1", "value": "Voet"}, {"name": "first1", "value": "D."}, {"name": "last2", "value": "Voet"}, {"name": "first2", "value": "J.&nbsp;G."}, {"name": "year", "value": "2004"}, {"name": "title", "value": "Biochemistry"}, {"name": "volume", "value": "1"}, {"name": "edition", "value": "3rd"}, {"name": "publisher", "value": "Wiley"}, {"name": "location", "value": "Hoboken, NJ"}, {"name": "isbn", "value": "978-0-471-19350-0"}]}, {"name": "Main", "values": [{"name": "1", "value": "Citric acid cycle"}, {"name": "2", "value": "oxidative phosphorylation"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Abrahams"}, {"name": "first1", "value": "J."}, {"name": "last2", "value": "Leslie"}, {"name": "first2", "value": "A."}, {"name": "last3", "value": "Lutter"}, {"name": "first3", "value": "R."}, {"name": "last4", "value": "Walker"}, {"name": "first4", "value": "J."}, {"name": "title", "value": "Structure at 2.8&nbsp;\u00c5 resolution of F1-ATPase from bovine heart mitochondria"}, {"name": "journal", "value": "Nature"}, {"name": "volume", "value": "370"}, {"name": "issue", "value": "6491"}, {"name": "pages", "value": "621\u2013628"}, {"name": "year", "value": "1994"}, {"name": "pmid", "value": "8065448"}, {"name": "doi", "value": "10.1038/370621a0"}]}, {"name": "cite journal ", "values": [{"name": "pmid", "value": "30713504"}, {"name": "volume", "value": "9, 1914"}, {"name": "title", "value": "Acidosis Maintains the Function of Brain Mitochondria in Hypoxia-Tolerant Triplefin Fish: A Strategy to Survive Acute Hypoxic Exposure?"}, {"name": "pmc", "value": "6346031"}, {"name": "date", "value": "January 2019"}, {"name": "journal", "value": "Front Physiol"}, {"name": "doi", "value": "10.3389/fphys.2018.01941"}, {"name": "last1", "value": "Devaux"}, {"name": "first1", "value": "JBL"}, {"name": "last2", "value": "Hedges"}, {"name": "first2", "value": "CP"}, {"name": "last3", "value": "Hickey"}, {"name": "first3", "value": "AJR"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Dahout-Gonzalez"}, {"name": "first1", "value": "C."}, {"name": "last2", "value": "Nury"}, {"name": "first2", "value": "H."}, {"name": "last3", "value": "Tr\u00e9z\u00e9guet"}, {"name": "first3", "value": "V."}, {"name": "last4", "value": "Lauquin"}, {"name": "first4", "value": "G."}, {"name": "last5", "value": "Pebay-Peyroula"}, {"name": "first5", "value": "E."}, {"name": "last6", "value": "Brandolin"}, {"name": "first6", "value": "G."}, {"name": "title", "value": "Molecular, functional, and pathological aspects of the mitochondrial ADP/ATP carrier"}, {"name": "journal", "value": "Physiology"}, {"name": "volume", "value": "21"}, {"name": "pages", "value": "242\u2013249"}, {"name": "year", "value": "2006"}, {"name": "pmid", "value": "16868313"}, {"name": "doi", "value": "10.1152/physiol.00005.2006"}, {"name": "issue", "value": "4"}]}, {"name": "Main", "values": [{"name": "1", "value": "Beta-oxidation"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Ronnett"}, {"name": "first1", "value": "G."}, {"name": "last2", "value": "Kim"}, {"name": "first2", "value": "E."}, {"name": "last3", "value": "Landree"}, {"name": "first3", "value": "L."}, {"name": "last4", "value": "Tu"}, {"name": "first4", "value": "Y."}, {"name": "title", "value": "Fatty acid metabolism as a target for obesity treatment"}, {"name": "journal", "value": "Physiol. Behav."}, {"name": "volume", "value": "85"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "25\u201335"}, {"name": "year", "value": "2005"}, {"name": "pmid", "value": "15878185"}, {"name": "doi", "value": "10.1016/j.physbeh.2005.04.014"}]}, {"name": "Main", "values": [{"name": "1", "value": "Ketone bodies"}]}, {"name": "Cite web", "values": [{"name": "url", "value": "http://www.epa.gov/iris/toxreviews/0128tr.pdf"}, {"name": "title", "value": "Integrated Risk Information System"}, {"name": "date", "value": "2013-03-15"}, {"name": "access-date", "value": "2019-02-01"}, {"name": "archive-url", "value": "https://web.archive.org/web/20150924074331/http://www.epa.gov/iris/toxreviews/0128tr.pdf"}, {"name": "archive-date", "value": "2015-09-24"}, {"name": "url-status", "value": "live"}]}], "id": 5}, {"title": "Glycolysis", "paragraphs": "{{Main|Glycolysis}}\n\nIn glycolysis, glucose and glycerol are metabolized to [[pyruvate]]. Glycolysis generates two equivalents of ATP through [[substrate-level phosphorylation|substrate phosphorylation]] catalyzed by two enzymes, [[Phosphoglycerate kinase|PGK]] and [[pyruvate kinase]]. Two equivalents of [[NADH]] are also produced, which can be oxidized via the [[electron transport chain]] and result in the generation of additional ATP by [[ATP synthase]]. The pyruvate generated as an end-product of glycolysis is a substrate for the [[citric acid cycle|Krebs Cycle]].<ref name=Voet>{{cite book |last1=Voet |first1=D. |last2=Voet |first2=J.&nbsp;G. | year=2004 | title=Biochemistry |volume=1 |edition=3rd | publisher= Wiley |location=Hoboken, NJ | isbn = 978-0-471-19350-0}}</ref>\n\nGlycolysis is viewed as consisting of two phases with five steps each. Phase 1, \"the preparatory phase\", glucose is converted to 2 d-glyceraldehyde -3-phosphate (g3p). One ATP is invested in the Step 1, and another ATP is invested in Step 3. Steps 1 and 3 of glycolysis are referred to as \"Priming Steps\". In Phase 2, two equivalents of g3p are converted to two pyruvates . In Step 7, two ATP are produced. In addition, in Step 10, two further equivalents of ATP are produced. In Steps 7 and 10, ATP is generated from ADP. A net of two ATPs are formed in the glycolysis cycle. The glycolysis pathway is later associated with the Citric Acid Cycle which produces additional equivalents of ATP.\n\n=====Regulation=====\nIn glycolysis, [[hexokinase]] is directly inhibited by its product, glucose-6-phosphate, and [[pyruvate kinase]] is inhibited by ATP itself. The main control point for the glycolytic pathway is [[phosphofructokinase]] (PFK), which is allosterically inhibited by high concentrations of ATP and activated by high concentrations of AMP. The inhibition of PFK by ATP is unusual, since ATP is also a substrate in the reaction catalyzed by PFK; the active form of the enzyme is a [[tetramer protein|tetramer]] that exists in two conformations, only one of which binds the second substrate fructose-6-phosphate (F6P). The protein has two [[binding site]]s for ATP&nbsp;\u2013 the [[active site]] is accessible in either protein conformation, but ATP binding to the inhibitor site stabilizes the conformation that binds F6P poorly.<ref name=\"Voet\" /> A number of other small molecules can compensate for the ATP-induced shift in equilibrium conformation and reactivate PFK, including [[cyclic AMP]], [[ammonium]] ions, inorganic phosphate, and fructose-1,6- and -2,6-biphosphate.<ref name=\"Voet\" />\n\n", "attributes": [{"name": "Main", "values": [{"name": "1", "value": "Glycolysis"}]}, {"name": "cite book ", "values": [{"name": "last1", "value": "Voet"}, {"name": "first1", "value": "D."}, {"name": "last2", "value": "Voet"}, {"name": "first2", "value": "J.&nbsp;G."}, {"name": "year", "value": "2004"}, {"name": "title", "value": "Biochemistry"}, {"name": "volume", "value": "1"}, {"name": "edition", "value": "3rd"}, {"name": "publisher", "value": "Wiley"}, {"name": "location", "value": "Hoboken, NJ"}, {"name": "isbn", "value": "978-0-471-19350-0"}]}], "id": 6}, {"title": "Regulation", "paragraphs": "In glycolysis, [[hexokinase]] is directly inhibited by its product, glucose-6-phosphate, and [[pyruvate kinase]] is inhibited by ATP itself. The main control point for the glycolytic pathway is [[phosphofructokinase]] (PFK), which is allosterically inhibited by high concentrations of ATP and activated by high concentrations of AMP. The inhibition of PFK by ATP is unusual, since ATP is also a substrate in the reaction catalyzed by PFK; the active form of the enzyme is a [[tetramer protein|tetramer]] that exists in two conformations, only one of which binds the second substrate fructose-6-phosphate (F6P). The protein has two [[binding site]]s for ATP&nbsp;\u2013 the [[active site]] is accessible in either protein conformation, but ATP binding to the inhibitor site stabilizes the conformation that binds F6P poorly.<ref name=\"Voet\" /> A number of other small molecules can compensate for the ATP-induced shift in equilibrium conformation and reactivate PFK, including [[cyclic AMP]], [[ammonium]] ions, inorganic phosphate, and fructose-1,6- and -2,6-biphosphate.<ref name=\"Voet\" />\n\n", "attributes": [], "id": 7}, {"title": "Citric acid cycle", "paragraphs": "{{Main|Citric acid cycle|oxidative phosphorylation}}\n\nIn the [[mitochondrion]], pyruvate is oxidized by the [[pyruvate dehydrogenase complex]] to the [[acetyl]] group, which is fully oxidized to [[carbon dioxide]] by the [[citric acid cycle]] (also known as the Krebs cycle). Every \"turn\" of the citric acid cycle produces two molecules of carbon dioxide, one equivalent of ATP [[guanosine triphosphate]] (GTP) through [[substrate-level phosphorylation]] catalyzed by [[succinyl-CoA synthetase]], as succinyl- CoA is converted to Succinate,  three equivalents of [[NADH]], and one equivalent of [[Flavin group|FADH<sub>2</sub>]]. NADH and FADH<sub>2</sub> are recycled (to NAD<sup>+</sup> and [[Flavin adenine dinucleotide|FAD]], respectively), generating additional ATP by [[oxidative phosphorylation]]. The oxidation of NADH results in the synthesis of 2\u20133 equivalents of ATP, and the oxidation of one FADH<sub>2</sub> yields between 1\u20132 equivalents of ATP.<ref name=\"Rich\" /> The majority of cellular ATP is generated by this process. Although the citric acid cycle itself does not involve molecular [[oxygen]], it is an obligately [[aerobic glycolysis|aerobic]] process because O<sub>2</sub> is used to recycle the NADH and FADH<sub>2</sub>. In the absence of oxygen, the citric acid cycle ceases.<ref name=\"Lodish\" />\n\nThe generation of ATP by the mitochondrion from cytosolic NADH relies on the [[malate-aspartate shuttle]] (and to a lesser extent, the [[glycerol-phosphate shuttle]]) because the inner mitochondrial membrane is impermeable to NADH and NAD<sup>+</sup>. Instead of transferring the generated NADH, a [[malate dehydrogenase]] enzyme converts [[oxaloacetate]] to [[malate]], which is translocated to the mitochondrial matrix. Another malate dehydrogenase-catalyzed reaction occurs in the opposite direction, producing oxaloacetate and NADH from the newly transported malate and the mitochondrion's interior store of NAD<sup>+</sup>. A [[transaminase]] converts the oxaloacetate to [[aspartate]] for transport back across the membrane and into the intermembrane space.<ref name=\"Lodish\" /><!--will put the antiporter/full cycle in the shuttle article-->\n\nIn oxidative phosphorylation, the passage of electrons from NADH and FADH<sub>2</sub> through the electron transport chain pumps [[proton]]s out of the mitochondrial matrix and into the intermembrane space. This pumping generates a [[proton motive force]] that is the net effect of a [[pH]] gradient and an [[electric potential]] gradient across the inner mitochondrial membrane. Flow of protons down this potential gradient&nbsp;\u2013 that is, from the intermembrane space to the matrix&nbsp;\u2013  yields ATP by [[ATP synthase]].<ref>{{cite journal |last1=Abrahams |first1=J. |last2=Leslie |first2=A. |last3=Lutter |first3=R. |last4=Walker |first4=J. | title = Structure at 2.8&nbsp;\u00c5 resolution of F1-ATPase from bovine heart mitochondria | journal = Nature | volume = 370 | issue = 6491 | pages = 621\u2013628 | year = 1994 |pmid=8065448 | doi = 10.1038/370621a0 }}</ref> Three ATP are produced per turn.\n\nAlthough oxygen consumption appears fundamental for the maintenance of the [[proton motive force]], in the event of oxygen shortage ([[Hypoxia (medical)|hypoxia]]), intracellular acidosis (mediated by enhanced glycolytic rates and ATP hydrolysis), contributes to mitochondrial membrane potential and directly drives ATP synthesis<ref>{{cite journal | pmid = 30713504 | volume=9, 1914 | title=Acidosis Maintains the Function of Brain Mitochondria in Hypoxia-Tolerant Triplefin Fish: A Strategy to Survive Acute Hypoxic Exposure? | pmc=6346031 | date=January 2019 | journal=Front Physiol | doi=10.3389/fphys.2018.01941 | last1 = Devaux | first1 = JBL | last2 = Hedges | first2 = CP | last3 = Hickey | first3 = AJR}}</ref>..  \n\nMost of the ATP synthesized in the mitochondria will be used for cellular processes in the cytosol; thus it must be exported from its site of synthesis in the mitochondrial matrix. ATP outward movement is favored by the membrane's electrochemical potential because the cytosol has a relatively positive charge compared to the relatively negative matrix. For every ATP transported out, it costs 1 H<sup>+</sup>. One ATP costs about 3  H<sup>+</sup>. Therefore, making and exporting one ATP requires  4H<sup>+.</sup> The inner membrane contains an [[antiporter]], the [[adenosine diphosphate|ADP]]/ATP translocase, which is an [[integral membrane protein]] used to exchange newly synthesized ATP in the matrix for [[adenosine diphosphate|ADP]] in the intermembrane space.<ref name=\"Brandolin\">{{cite journal |last1=Dahout-Gonzalez |first1=C. |last2=Nury |first2=H. |last3=Tr\u00e9z\u00e9guet |first3=V. |last4=Lauquin |first4=G. |last5=Pebay-Peyroula |first5=E. |last6=Brandolin |first6=G. | title = Molecular, functional, and pathological aspects of the mitochondrial ADP/ATP carrier | journal = Physiology | volume = 21 | pages = 242\u2013249 | year = 2006| pmid = 16868313 | doi=10.1152/physiol.00005.2006 | issue = 4 }}</ref> This translocase is driven by the membrane potential, as it results in the movement of about 4 negative charges out of the mitochondrial membrane in exchange for 3 negative charges moved inside. However, it is also necessary to transport phosphate into the mitochondrion; the phosphate carrier moves a proton in with each phosphate, partially dissipating the proton gradient. After completing glycolysis, the Citric Acid Cycle, electrons transport chain, and oxidative phosphorylation, approximately 30\u201338 ATP are produced per glucose.\n\n=====Regulation=====\nThe citric acid cycle is regulated mainly by the availability of key substrates, particularly the ratio of NAD<sup>+</sup> to NADH and the concentrations of [[calcium]], inorganic phosphate, ATP, [[adenosine diphosphate|ADP]], and AMP. [[Citrate]]&nbsp;\u2013 the ion that gives its name to the cycle&nbsp;\u2013 is a feedback inhibitor of [[citrate synthase]] and also inhibits PFK, providing a direct link between the regulation of the citric acid cycle and glycolysis.<ref name=\"Voet\" />\n\n", "attributes": [{"name": "Main", "values": [{"name": "1", "value": "Citric acid cycle"}, {"name": "2", "value": "oxidative phosphorylation"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Abrahams"}, {"name": "first1", "value": "J."}, {"name": "last2", "value": "Leslie"}, {"name": "first2", "value": "A."}, {"name": "last3", "value": "Lutter"}, {"name": "first3", "value": "R."}, {"name": "last4", "value": "Walker"}, {"name": "first4", "value": "J."}, {"name": "title", "value": "Structure at 2.8&nbsp;\u00c5 resolution of F1-ATPase from bovine heart mitochondria"}, {"name": "journal", "value": "Nature"}, {"name": "volume", "value": "370"}, {"name": "issue", "value": "6491"}, {"name": "pages", "value": "621\u2013628"}, {"name": "year", "value": "1994"}, {"name": "pmid", "value": "8065448"}, {"name": "doi", "value": "10.1038/370621a0"}]}, {"name": "cite journal ", "values": [{"name": "pmid", "value": "30713504"}, {"name": "volume", "value": "9, 1914"}, {"name": "title", "value": "Acidosis Maintains the Function of Brain Mitochondria in Hypoxia-Tolerant Triplefin Fish: A Strategy to Survive Acute Hypoxic Exposure?"}, {"name": "pmc", "value": "6346031"}, {"name": "date", "value": "January 2019"}, {"name": "journal", "value": "Front Physiol"}, {"name": "doi", "value": "10.3389/fphys.2018.01941"}, {"name": "last1", "value": "Devaux"}, {"name": "first1", "value": "JBL"}, {"name": "last2", "value": "Hedges"}, {"name": "first2", "value": "CP"}, {"name": "last3", "value": "Hickey"}, {"name": "first3", "value": "AJR"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Dahout-Gonzalez"}, {"name": "first1", "value": "C."}, {"name": "last2", "value": "Nury"}, {"name": "first2", "value": "H."}, {"name": "last3", "value": "Tr\u00e9z\u00e9guet"}, {"name": "first3", "value": "V."}, {"name": "last4", "value": "Lauquin"}, {"name": "first4", "value": "G."}, {"name": "last5", "value": "Pebay-Peyroula"}, {"name": "first5", "value": "E."}, {"name": "last6", "value": "Brandolin"}, {"name": "first6", "value": "G."}, {"name": "title", "value": "Molecular, functional, and pathological aspects of the mitochondrial ADP/ATP carrier"}, {"name": "journal", "value": "Physiology"}, {"name": "volume", "value": "21"}, {"name": "pages", "value": "242\u2013249"}, {"name": "year", "value": "2006"}, {"name": "pmid", "value": "16868313"}, {"name": "doi", "value": "10.1152/physiol.00005.2006"}, {"name": "issue", "value": "4"}]}], "id": 8}, {"title": "Regulation", "paragraphs": "The citric acid cycle is regulated mainly by the availability of key substrates, particularly the ratio of NAD<sup>+</sup> to NADH and the concentrations of [[calcium]], inorganic phosphate, ATP, [[adenosine diphosphate|ADP]], and AMP. [[Citrate]]&nbsp;\u2013 the ion that gives its name to the cycle&nbsp;\u2013 is a feedback inhibitor of [[citrate synthase]] and also inhibits PFK, providing a direct link between the regulation of the citric acid cycle and glycolysis.<ref name=\"Voet\" />\n\n", "attributes": [], "id": 9}, {"title": "Beta oxidation", "paragraphs": "{{Main|Beta-oxidation}}\nIn the presence of air and various cofactors and enzymes, fatty acids are converted to [[acetyl-CoA]]. The pathway is called [[beta-oxidation]]. Each cycle of beta-oxidation shortens the fatty acid chain by two carbon atoms and produces one equivalent each of acetyl-CoA, NADH, and FADH<sub>2</sub>. The acetyl-CoA is metabolized by the citric acid cycle to generate ATP, while the NADH and FADH<sub>2</sub> are used  by oxidative phosphorylation to generate ATP.  Dozens of ATP equivalents are generated by the beta-oxidation of a single long acyl chain.<ref>{{cite journal |last1=Ronnett |first1=G. |last2=Kim |first2=E. |last3=Landree |first3=L. |last4=Tu |first4=Y. | title = Fatty acid metabolism as a target for obesity treatment | journal = Physiol. Behav. | volume = 85 | issue = 1 | pages = 25\u201335 | year = 2005 | pmid = 15878185 | doi=10.1016/j.physbeh.2005.04.014 }}</ref>\n\n=====Regulation=====\nIn oxidative phosphorylation, the key control point is the reaction catalyzed by [[cytochrome c oxidase]], which is regulated by the availability of its substrate&nbsp;\u2013 the reduced form of [[cytochrome c]]. The amount of reduced cytochrome c available is directly related to the amounts of other substrates:\n\n:<math chem>\n\\frac12 \\ce{NADH} + \\ce{cyt}\\ \\ce{c_{ox}} + \\ce{ADP} + \\ce{P_i} \\rightleftharpoons\n\\frac12 \\ce{NAD^+} + \\ce{cyt}\\ \\ce{c_{red}} + \\ce{ATP}\n</math>\n\nwhich directly implies this equation:\n\n:<math>\n\\frac{[\\mathrm{cyt~c_{red}}]}{[\\mathrm{cyt~c_{ox}}]} = \\left(\\frac{[\\mathrm{NADH}]}{[\\mathrm{NAD}]^{+}}\\right)^{\\frac{1}{2}}\\left(\\frac{[\\mathrm{ADP}] [\\mathrm{P_i}]}{[\\mathrm{ATP}]}\\right)K_\\mathrm{eq}\n</math>\n\nThus, a high ratio of [NADH] to [NAD<sup>+</sup>] or a high ratio of [ADP][P<sub>i</sub>] to [ATP] imply a high amount of reduced cytochrome c and a high level of cytochrome c oxidase activity.<ref name=\"Voet\" /> An additional level of regulation is introduced by the transport rates of ATP and NADH between the mitochondrial matrix and the cytoplasm.<ref name=\"Brandolin\" />\n\n", "attributes": [{"name": "Main", "values": [{"name": "1", "value": "Beta-oxidation"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Ronnett"}, {"name": "first1", "value": "G."}, {"name": "last2", "value": "Kim"}, {"name": "first2", "value": "E."}, {"name": "last3", "value": "Landree"}, {"name": "first3", "value": "L."}, {"name": "last4", "value": "Tu"}, {"name": "first4", "value": "Y."}, {"name": "title", "value": "Fatty acid metabolism as a target for obesity treatment"}, {"name": "journal", "value": "Physiol. Behav."}, {"name": "volume", "value": "85"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "25\u201335"}, {"name": "year", "value": "2005"}, {"name": "pmid", "value": "15878185"}, {"name": "doi", "value": "10.1016/j.physbeh.2005.04.014"}]}], "id": 10}, {"title": "Regulation", "paragraphs": "In oxidative phosphorylation, the key control point is the reaction catalyzed by [[cytochrome c oxidase]], which is regulated by the availability of its substrate&nbsp;\u2013 the reduced form of [[cytochrome c]]. The amount of reduced cytochrome c available is directly related to the amounts of other substrates:\n\n:<math chem>\n\\frac12 \\ce{NADH} + \\ce{cyt}\\ \\ce{c_{ox}} + \\ce{ADP} + \\ce{P_i} \\rightleftharpoons\n\\frac12 \\ce{NAD^+} + \\ce{cyt}\\ \\ce{c_{red}} + \\ce{ATP}\n</math>\n\nwhich directly implies this equation:\n\n:<math>\n\\frac{[\\mathrm{cyt~c_{red}}]}{[\\mathrm{cyt~c_{ox}}]} = \\left(\\frac{[\\mathrm{NADH}]}{[\\mathrm{NAD}]^{+}}\\right)^{\\frac{1}{2}}\\left(\\frac{[\\mathrm{ADP}] [\\mathrm{P_i}]}{[\\mathrm{ATP}]}\\right)K_\\mathrm{eq}\n</math>\n\nThus, a high ratio of [NADH] to [NAD<sup>+</sup>] or a high ratio of [ADP][P<sub>i</sub>] to [ATP] imply a high amount of reduced cytochrome c and a high level of cytochrome c oxidase activity.<ref name=\"Voet\" /> An additional level of regulation is introduced by the transport rates of ATP and NADH between the mitochondrial matrix and the cytoplasm.<ref name=\"Brandolin\" />\n\n", "attributes": [], "id": 11}, {"title": "Ketosis", "paragraphs": "{{Main|Ketone bodies}}\n\nKetone bodies can be used as fuels, yielding 22 ATP and 2 [[Guanosine triphosphate|GTP]] molecules per acetoacetate molecule when oxidized in the mitochondria. Ketone bodies are transported from the [[liver]] to other tissues, where [[acetoacetate]] and [[beta-Hydroxybutyric acid|''beta''-hydroxybutyrate]] can be reconverted to [[acetyl-CoA]] to produce reducing equivalents (NADH and FADH<sub>2</sub>), via the [[citric acid cycle]]. Ketone bodies cannot be used as fuel by the liver, because the liver lacks the enzyme \u03b2-ketoacyl-CoA transferase, also called thiophorase.  [[Acetoacetate]] in low concentrations is taken up by the liver and undergoes detoxification through the methylglyoxal pathway which ends with lactate. [[Acetoacetate]] in high concentrations is absorbed by cells other than those in the liver and enters a different pathway via [[1,2-propanediol]].  Though the pathway follows a different series of steps requiring ATP, 1,2-propanediol can be turned into pyruvate.<ref name=\"Environmental Protection Agency; TOXICOLOGICAL REVIEW OF ACETONE (CAS No. 67-64-1)\">{{Cite web| url=http://www.epa.gov/iris/toxreviews/0128tr.pdf| title=Integrated Risk Information System| date=2013-03-15| access-date=2019-02-01| archive-url=https://web.archive.org/web/20150924074331/http://www.epa.gov/iris/toxreviews/0128tr.pdf| archive-date=2015-09-24| url-status=live}}</ref>\n\n", "attributes": [{"name": "Main", "values": [{"name": "1", "value": "Ketone bodies"}]}, {"name": "Cite web", "values": [{"name": "url", "value": "http://www.epa.gov/iris/toxreviews/0128tr.pdf"}, {"name": "title", "value": "Integrated Risk Information System"}, {"name": "date", "value": "2013-03-15"}, {"name": "access-date", "value": "2019-02-01"}, {"name": "archive-url", "value": "https://web.archive.org/web/20150924074331/http://www.epa.gov/iris/toxreviews/0128tr.pdf"}, {"name": "archive-date", "value": "2015-09-24"}, {"name": "url-status", "value": "live"}]}], "id": 12}, {"title": "Production, anaerobic conditions", "paragraphs": "[[fermentation (biochemistry)|Fermentation]] is the metabolism of organic compounds in the absence of air. It involves [[substrate-level phosphorylation]] in the absence of a respiratory [[electron transport chain]]. The equation for the oxidation of glucose to [[lactic acid]] is:\n: {{chem|C|6|H|12|O|6}} \u2192 2&nbsp;{{chem|CH|3|CH(OH)COOH}} + 2&nbsp;ATP\n\n[[Anaerobic respiration]] is respiration in the absence of {{chem|link=oxygen|O|2}}. Prokaryotes can utilize a variety of electron acceptors. These include [[nitrate]], [[sulfate]], and carbon dioxide.\n\n", "attributes": [{"name": "chem", "values": [{"name": "1", "value": "C"}, {"name": "2", "value": "6"}, {"name": "3", "value": "H"}, {"name": "4", "value": "12"}, {"name": "5", "value": "O"}, {"name": "6", "value": "6"}]}, {"name": "chem", "values": [{"name": "1", "value": "CH"}, {"name": "2", "value": "3"}, {"name": "3", "value": "CH(OH)COOH"}]}, {"name": "chem", "values": [{"name": "link", "value": "oxygen"}, {"name": "1", "value": "O"}, {"name": "2", "value": "2"}]}], "id": 13}, {"title": "ATP replenishment by nucleoside diphosphate kinases", "paragraphs": "ATP can also be synthesized through several so-called \"replenishment\" reactions catalyzed by the enzyme families of [[nucleoside diphosphate kinase]]s (NDKs), which use other nucleoside triphosphates as a high-energy phosphate donor, and the [[ATP:guanido phosphotransferase family|ATP:guanido-phosphotransferase]] family.\n\n", "attributes": [], "id": 14}, {"title": "ATP production during photosynthesis", "paragraphs": "In plants, ATP is synthesized in the [[thylakoid membrane]] of the [[chloroplast]].  The process is called photophosphorylation. The \"machinery\" is similar to that in mitochondria except that light energy is used to pump protons across a membrane to produce a proton-motive force. ATP synthase then ensues exactly as in oxidative phosphorylation.<ref>{{cite journal | last = Allen | first = J. | title = Photosynthesis of ATP-electrons, proton pumps, rotors, and poise | journal = Cell | volume = 110 | issue = 3 | pages = 273\u2013276 | year = 2002 | pmid = 12176312 | doi = 10.1016/S0092-8674(02)00870-X }}</ref> Some of the ATP produced in the chloroplasts is consumed in the [[Calvin cycle]], which produces [[triose]] sugars.\n\n", "attributes": [{"name": "cite journal ", "values": [{"name": "last", "value": "Allen"}, {"name": "first", "value": "J."}, {"name": "title", "value": "Photosynthesis of ATP-electrons, proton pumps, rotors, and poise"}, {"name": "journal", "value": "Cell"}, {"name": "volume", "value": "110"}, {"name": "issue", "value": "3"}, {"name": "pages", "value": "273\u2013276"}, {"name": "year", "value": "2002"}, {"name": "pmid", "value": "12176312"}, {"name": "doi", "value": "10.1016/S0092-8674(02)00870-X"}]}], "id": 15}, {"title": "ATP recycling", "paragraphs": "The total quantity of ATP in the human body is about 0.2&nbsp;[[Mole (unit)|mole]]s. The majority of ATP is recycled from [[adenosine diphosphate|ADP]] by the aforementioned processes. Thus, at any given time, the total amount of ATP + [[adenosine diphosphate|ADP]] remains fairly constant.\n\nThe energy used by human cells requires the [[hydrolysis]] of 100 to 150&nbsp;moles of ATP daily, which is around 50 to 75&nbsp;kg. A human will typically use up his or her body weight of ATP over the course of the day. Each equivalent of ATP is recycled 500\u2013750 times during a single day ({{nowrap|100 / 0.2 {{=}} 500}}).{{Citation needed|date=January 2020}}\n\n[[Image:Rossmann-fold-1g5q.png|thumb|An example of the Rossmann fold, a [[structural domain]] of a [[decarboxylase]] enzyme from the bacterium ''[[Staphylococcus epidermidis]]'' ({{PDB|1G5Q}}) with a bound [[flavin mononucleotide]] cofactor.]]\n\n", "attributes": [{"name": "nowrap", "values": [{"name": "1", "value": "100 / 0.2 {{=}} 500"}]}, {"name": "Citation needed", "values": [{"name": "date", "value": "January 2020"}]}, {"name": "PDB", "values": [{"name": "1", "value": "1G5Q"}]}], "id": 16}, {"title": "Biochemical functions", "paragraphs": "===Intracellular signaling===\nATP is involved in [[signal transduction]] by serving as substrate for kinases, enzymes that transfer phosphate groups.  Kinases are the most common ATP-binding proteins.  They share a small number of common folds.<ref name=Scheeff>{{cite journal |last1=Scheeff |first1=E. |last2=Bourne |first2=P. | title = Structural evolution of the protein kinase-like superfamily |pmc=1261164 | doi = 10.1371/journal.pcbi.0010049 | journal = PLoS Comput. Biol. | volume = 1 | issue = 5 | pages = e49 | year = 2005 | pmid = 16244704}}</ref>  [[Phosphorylation]] of a protein by a kinase can activate a cascade such as the [[mitogen-activated protein kinase]] cascade.<ref>{{cite journal |last1=Mishra |first1=N. |last2=Tuteja |first2=R. |last3=Tuteja |first3=N. | title = Signaling through MAP kinase networks in plants | journal = Arch. Biochem. Biophys. | volume = 452 | issue = 1 | pages = 55\u201368 | year = 2006 | pmid = 16806044 | doi = 10.1016/j.abb.2006.05.001 }}</ref>\n\nATP is also a substrate of [[adenylate cyclase]], most commonly in [[G protein\u2013coupled receptor|G protein-coupled receptor]] signal transduction pathways and is transformed to [[second messenger]], cyclic AMP, which is involved in triggering calcium signals by the release of calcium from intracellular stores.<ref>{{cite journal |last1=Kamenetsky |first1=M. |last2=Middelhaufe |first2=S. |last3=Bank |first3=E. |last4=Levin |first4=L. |last5=Buck |first5=J. |last6=Steegborn |first6=C. | title = Molecular details of cAMP generation in mammalian cells: a tale of two systems | journal = J. Mol. Biol. | volume = 362 | issue = 4 | pages = 623\u2013639 | year = 2006 | pmid = 16934836 | doi = 10.1016/j.jmb.2006.07.045 | pmc = 3662476}}</ref> This form of signal transduction is particularly important in brain function, although it is involved in the regulation of a multitude of other cellular processes.<ref>{{cite journal |last1=Hanoune |first1=J. |last2=Defer |first2=N. | title = Regulation and role of adenylyl cyclase isoforms | journal = Annu. Rev. Pharmacol. Toxicol. | volume = 41 | pages = 145\u2013174 | year = 2001| pmid = 11264454 | doi = 10.1146/annurev.pharmtox.41.1.145 }}</ref>\n\n===DNA and RNA synthesis===\nATP is one of four \"monomers\" required in the synthesis of [[RNA]]. The process is promoted by [[RNA polymerase]]s.<ref>{{cite journal |last1=Joyce |first1=C.&nbsp;M. |last2=Steitz |first2=T.&nbsp;A. |title=Polymerase structures and function: variations on a theme? |journal=J. Bacteriol. |volume=177 |issue=22 |pages=6321\u20136329 |year=1995 |pmid=7592405 |pmc=177480 |doi=10.1128/jb.177.22.6321-6329.1995}}</ref> A similar process occurs in the formation of DNA, except that ATP is first converted to the [[deoxyribonucleotide]] dATP.  Like many condensation reactions in nature, [[DNA replication]] and [[DNA transcription]] also consumes ATP.\n\n===Amino acid activation in protein synthesis===\n{{main|Amino acid activation}}\n[[Aminoacyl-tRNA synthetase]] enzymes consume ATP in the attachment tRNA to amino acids, forming aminoacyl-tRNA complexes. Aminoacyl transferase binds AMP-amino acid to tRNA. The coupling reaction proceeds in two steps:\n\n# aa + ATP \u27f6 aa-AMP + [[pyrophosphate|PP<sub>i</sub>]]\n# aa-AMP + tRNA \u27f6 aa-tRNA + AMP\n\nThe amino acid is coupled to the penultimate nucleotide at the 3\u2032-end of the tRNA (the A in the sequence CCA) via an ester bond (roll over in illustration).\n\n===ATP binding cassette transporter===\nTransporting chemicals out of a cell against a gradient is often associated with ATP hydrolysis.  Transport is mediated by [[ATP binding cassette transporter]]s.  The human genome encodes 48 ABC transporters, that are used for exporting drugs, lipids, and other compounds.<ref>{{cite journal|title=Mammalian ABC transporters in health and disease|authors=Borst, P.; Elferink, R. Oude|journal=Annual Review of Biochemistry|year=2002|volume=71|pages=537\u2013592|doi=10.1146/annurev.biochem.71.102301.093055|pmid=12045106|url=https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf|access-date=2018-04-20|archive-url=https://web.archive.org/web/20180421032744/https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf|archive-date=2018-04-21|url-status=live}}</ref>\n\n===Extracellular signalling and neurotransmision===\nCells secrete ATP to communicate with other cells in a process called [[purinergic signalling]]. ATP serves as a neurotransmitter in many parts of the nervous system, modulates ciliary beating, affects vascular oxygen supply etc.  ATP is either secreted directly across the cell membrane through channel proteins<ref name=\"RomanovLasher2018\">{{cite journal|last1=Romanov|first1=Roman A.|last2=Lasher|first2=Robert S.|last3=High|first3=Brigit|last4=Savidge|first4=Logan E.|last5=Lawson|first5=Adam|last6=Rogachevskaja|first6=Olga A.|last7=Zhao|first7=Haitian|last8=Rogachevsky|first8=Vadim V.|last9=Bystrova|first9=Marina F.|last10=Churbanov|first10=Gleb D.|last11=Adameyko|first11=Igor|last12=Harkany|first12=Tibor|last13=Yang|first13=Ruibiao|last14=Kidd|first14=Grahame J.|last15=Marambaud|first15=Philippe|last16=Kinnamon|first16=John C.|last17=Kolesnikov|first17=Stanislav S.|last18=Finger|first18=Thomas E.|title=Chemical synapses without synaptic vesicles: Purinergic neurotransmission through a CALHM1 channel-mitochondrial signaling complex|journal=Science Signaling|volume=11|issue=529|year=2018|pages=eaao1815|issn=1945-0877|doi=10.1126/scisignal.aao1815|pmid=29739879|pmc=5966022}}</ref><ref name=\"Dahl2015\">{{cite journal|last1=Dahl|first1=Gerhard|title=ATP release through pannexon channels|journal=Philosophical Transactions of the Royal Society B: Biological Sciences|volume=370|issue=1672|year=2015|pages=20140191|issn=0962-8436|doi=10.1098/rstb.2014.0191|pmid=26009770|pmc=4455760}}</ref> or is pumped into vesicles<ref name=\"LarssonSawada2012\">{{cite journal|last1=Larsson|first1=Max|last2=Sawada|first2=Keisuke|last3=Morland|first3=Cecilie|last4=Hiasa|first4=Miki|last5=Ormel|first5=Lasse|last6=Moriyama|first6=Yoshinori|last7=Gundersen|first7=Vidar|title=Functional and Anatomical Identification of a Vesicular Transporter Mediating Neuronal ATP Release|journal=Cerebral Cortex|volume=22|issue=5|year=2012|pages=1203\u20131214|issn=1460-2199|doi=10.1093/cercor/bhr203|pmid=21810784}}</ref> which then [[exocytosis|fuse]] with the membrane. Cells detect ATP using the [[purinergic receptor]] proteins P2X and P2Y.\n\n=== Protein solubility ===\nATP has recently been proposed to act as a biological [[hydrotrope]]<ref>{{Cite journal|last=Hyman|first=Anthony A.|last2=Krishnan|first2=Yamuna|last3=Alberti|first3=Simon|last4=Wang|first4=Jie|last5=Saha|first5=Shambaditya|last6=Malinovska|first6=Liliana|last7=Patel|first7=Avinash|date=2017-05-19|title=ATP as a biological hydrotrope|journal=Science|language=en|volume=356|issue=6339|pages=753\u2013756|doi=10.1126/science.aaf6846|issn=0036-8075|pmid=28522535}}</ref> and has been shown to affect proteome-wide solubility.<ref>{{Cite journal|last=Savitski|first=Mikhail M.|last2=Bantscheff|first2=Marcus|last3=Huber|first3=Wolfgang|last4=Dominic Helm|last5=G\u00fcnthner|first5=Ina|last6=Werner|first6=Thilo|last7=Kurzawa|first7=Nils|last8=Sridharan|first8=Sindhuja|date=2019-03-11|title=Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP|journal=Nature Communications|language=en|volume=10|issue=1|pages=1155|doi=10.1038/s41467-019-09107-y|pmid=30858367|pmc=6411743|issn=2041-1723}}</ref>\n\n", "attributes": [{"name": "cite journal ", "values": [{"name": "last1", "value": "Scheeff"}, {"name": "first1", "value": "E."}, {"name": "last2", "value": "Bourne"}, {"name": "first2", "value": "P."}, {"name": "title", "value": "Structural evolution of the protein kinase-like superfamily"}, {"name": "pmc", "value": "1261164"}, {"name": "doi", "value": "10.1371/journal.pcbi.0010049"}, {"name": "journal", "value": "PLoS Comput. Biol."}, {"name": "volume", "value": "1"}, {"name": "issue", "value": "5"}, {"name": "pages", "value": "e49"}, {"name": "year", "value": "2005"}, {"name": "pmid", "value": "16244704"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Mishra"}, {"name": "first1", "value": "N."}, {"name": "last2", "value": "Tuteja"}, {"name": "first2", "value": "R."}, {"name": "last3", "value": "Tuteja"}, {"name": "first3", "value": "N."}, {"name": "title", "value": "Signaling through MAP kinase networks in plants"}, {"name": "journal", "value": "Arch. Biochem. Biophys."}, {"name": "volume", "value": "452"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "55\u201368"}, {"name": "year", "value": "2006"}, {"name": "pmid", "value": "16806044"}, {"name": "doi", "value": "10.1016/j.abb.2006.05.001"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Kamenetsky"}, {"name": "first1", "value": "M."}, {"name": "last2", "value": "Middelhaufe"}, {"name": "first2", "value": "S."}, {"name": "last3", "value": "Bank"}, {"name": "first3", "value": "E."}, {"name": "last4", "value": "Levin"}, {"name": "first4", "value": "L."}, {"name": "last5", "value": "Buck"}, {"name": "first5", "value": "J."}, {"name": "last6", "value": "Steegborn"}, {"name": "first6", "value": "C."}, {"name": "title", "value": "Molecular details of cAMP generation in mammalian cells: a tale of two systems"}, {"name": "journal", "value": "J. Mol. Biol."}, {"name": "volume", "value": "362"}, {"name": "issue", "value": "4"}, {"name": "pages", "value": "623\u2013639"}, {"name": "year", "value": "2006"}, {"name": "pmid", "value": "16934836"}, {"name": "doi", "value": "10.1016/j.jmb.2006.07.045"}, {"name": "pmc", "value": "3662476"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Hanoune"}, {"name": "first1", "value": "J."}, {"name": "last2", "value": "Defer"}, {"name": "first2", "value": "N."}, {"name": "title", "value": "Regulation and role of adenylyl cyclase isoforms"}, {"name": "journal", "value": "Annu. Rev. Pharmacol. Toxicol."}, {"name": "volume", "value": "41"}, {"name": "pages", "value": "145\u2013174"}, {"name": "year", "value": "2001"}, {"name": "pmid", "value": "11264454"}, {"name": "doi", "value": "10.1146/annurev.pharmtox.41.1.145"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Joyce"}, {"name": "first1", "value": "C.&nbsp;M."}, {"name": "last2", "value": "Steitz"}, {"name": "first2", "value": "T.&nbsp;A."}, {"name": "title", "value": "Polymerase structures and function: variations on a theme?"}, {"name": "journal", "value": "J. Bacteriol."}, {"name": "volume", "value": "177"}, {"name": "issue", "value": "22"}, {"name": "pages", "value": "6321\u20136329"}, {"name": "year", "value": "1995"}, {"name": "pmid", "value": "7592405"}, {"name": "pmc", "value": "177480"}, {"name": "doi", "value": "10.1128/jb.177.22.6321-6329.1995"}]}, {"name": "main", "values": [{"name": "1", "value": "Amino acid activation"}]}, {"name": "cite journal", "values": [{"name": "title", "value": "Mammalian ABC transporters in health and disease"}, {"name": "authors", "value": "Borst, P.; Elferink, R. Oude"}, {"name": "journal", "value": "Annual Review of Biochemistry"}, {"name": "year", "value": "2002"}, {"name": "volume", "value": "71"}, {"name": "pages", "value": "537\u2013592"}, {"name": "doi", "value": "10.1146/annurev.biochem.71.102301.093055"}, {"name": "pmid", "value": "12045106"}, {"name": "url", "value": "https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf"}, {"name": "access-date", "value": "2018-04-20"}, {"name": "archive-url", "value": "https://web.archive.org/web/20180421032744/https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf"}, {"name": "archive-date", "value": "2018-04-21"}, {"name": "url-status", "value": "live"}]}, {"name": "cite journal", "values": [{"name": "last1", "value": "Romanov"}, {"name": "first1", "value": "Roman A."}, {"name": "last2", "value": "Lasher"}, {"name": "first2", "value": "Robert S."}, {"name": "last3", "value": "High"}, {"name": "first3", "value": "Brigit"}, {"name": "last4", "value": "Savidge"}, {"name": "first4", "value": "Logan E."}, {"name": "last5", "value": "Lawson"}, {"name": "first5", "value": "Adam"}, {"name": "last6", "value": "Rogachevskaja"}, {"name": "first6", "value": "Olga A."}, {"name": "last7", "value": "Zhao"}, {"name": "first7", "value": "Haitian"}, {"name": "last8", "value": "Rogachevsky"}, {"name": "first8", "value": "Vadim V."}, {"name": "last9", "value": "Bystrova"}, {"name": "first9", "value": "Marina F."}, {"name": "last10", "value": "Churbanov"}, {"name": "first10", "value": "Gleb D."}, {"name": "last11", "value": "Adameyko"}, {"name": "first11", "value": "Igor"}, {"name": "last12", "value": "Harkany"}, {"name": "first12", "value": "Tibor"}, {"name": "last13", "value": "Yang"}, {"name": "first13", "value": "Ruibiao"}, {"name": "last14", "value": "Kidd"}, {"name": "first14", "value": "Grahame J."}, {"name": "last15", "value": "Marambaud"}, {"name": "first15", "value": "Philippe"}, {"name": "last16", "value": "Kinnamon"}, {"name": "first16", "value": "John C."}, {"name": "last17", "value": "Kolesnikov"}, {"name": "first17", "value": "Stanislav S."}, {"name": "last18", "value": "Finger"}, {"name": "first18", "value": "Thomas E."}, {"name": "title", "value": "Chemical synapses without synaptic vesicles: Purinergic neurotransmission through a CALHM1 channel-mitochondrial signaling complex"}, {"name": "journal", "value": "Science Signaling"}, {"name": "volume", "value": "11"}, {"name": "issue", "value": "529"}, {"name": "year", "value": "2018"}, {"name": "pages", "value": "eaao1815"}, {"name": "issn", "value": "1945-0877"}, {"name": "doi", "value": "10.1126/scisignal.aao1815"}, {"name": "pmid", "value": "29739879"}, {"name": "pmc", "value": "5966022"}]}, {"name": "cite journal", "values": [{"name": "last1", "value": "Dahl"}, {"name": "first1", "value": "Gerhard"}, {"name": "title", "value": "ATP release through pannexon channels"}, {"name": "journal", "value": "Philosophical Transactions of the Royal Society B: Biological Sciences"}, {"name": "volume", "value": "370"}, {"name": "issue", "value": "1672"}, {"name": "year", "value": "2015"}, {"name": "pages", "value": "20140191"}, {"name": "issn", "value": "0962-8436"}, {"name": "doi", "value": "10.1098/rstb.2014.0191"}, {"name": "pmid", "value": "26009770"}, {"name": "pmc", "value": "4455760"}]}, {"name": "cite journal", "values": [{"name": "last1", "value": "Larsson"}, {"name": "first1", "value": "Max"}, {"name": "last2", "value": "Sawada"}, {"name": "first2", "value": "Keisuke"}, {"name": "last3", "value": "Morland"}, {"name": "first3", "value": "Cecilie"}, {"name": "last4", "value": "Hiasa"}, {"name": "first4", "value": "Miki"}, {"name": "last5", "value": "Ormel"}, {"name": "first5", "value": "Lasse"}, {"name": "last6", "value": "Moriyama"}, {"name": "first6", "value": "Yoshinori"}, {"name": "last7", "value": "Gundersen"}, {"name": "first7", "value": "Vidar"}, {"name": "title", "value": "Functional and Anatomical Identification of a Vesicular Transporter Mediating Neuronal ATP Release"}, {"name": "journal", "value": "Cerebral Cortex"}, {"name": "volume", "value": "22"}, {"name": "issue", "value": "5"}, {"name": "year", "value": "2012"}, {"name": "pages", "value": "1203\u20131214"}, {"name": "issn", "value": "1460-2199"}, {"name": "doi", "value": "10.1093/cercor/bhr203"}, {"name": "pmid", "value": "21810784"}]}, {"name": "Cite journal", "values": [{"name": "last", "value": "Hyman"}, {"name": "first", "value": "Anthony A."}, {"name": "last2", "value": "Krishnan"}, {"name": "first2", "value": "Yamuna"}, {"name": "last3", "value": "Alberti"}, {"name": "first3", "value": "Simon"}, {"name": "last4", "value": "Wang"}, {"name": "first4", "value": "Jie"}, {"name": "last5", "value": "Saha"}, {"name": "first5", "value": "Shambaditya"}, {"name": "last6", "value": "Malinovska"}, {"name": "first6", "value": "Liliana"}, {"name": "last7", "value": "Patel"}, {"name": "first7", "value": "Avinash"}, {"name": "date", "value": "2017-05-19"}, {"name": "title", "value": "ATP as a biological hydrotrope"}, {"name": "journal", "value": "Science"}, {"name": "language", "value": "en"}, {"name": "volume", "value": "356"}, {"name": "issue", "value": "6339"}, {"name": "pages", "value": "753\u2013756"}, {"name": "doi", "value": "10.1126/science.aaf6846"}, {"name": "issn", "value": "0036-8075"}, {"name": "pmid", "value": "28522535"}]}, {"name": "Cite journal", "values": [{"name": "last", "value": "Savitski"}, {"name": "first", "value": "Mikhail M."}, {"name": "last2", "value": "Bantscheff"}, {"name": "first2", "value": "Marcus"}, {"name": "last3", "value": "Huber"}, {"name": "first3", "value": "Wolfgang"}, {"name": "last4", "value": "Dominic Helm"}, {"name": "last5", "value": "G\u00fcnthner"}, {"name": "first5", "value": "Ina"}, {"name": "last6", "value": "Werner"}, {"name": "first6", "value": "Thilo"}, {"name": "last7", "value": "Kurzawa"}, {"name": "first7", "value": "Nils"}, {"name": "last8", "value": "Sridharan"}, {"name": "first8", "value": "Sindhuja"}, {"name": "date", "value": "2019-03-11"}, {"name": "title", "value": "Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP"}, {"name": "journal", "value": "Nature Communications"}, {"name": "language", "value": "en"}, {"name": "volume", "value": "10"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "1155"}, {"name": "doi", "value": "10.1038/s41467-019-09107-y"}, {"name": "pmid", "value": "30858367"}, {"name": "pmc", "value": "6411743"}, {"name": "issn", "value": "2041-1723"}]}], "id": 17}, {"title": "Intracellular signaling", "paragraphs": "ATP is involved in [[signal transduction]] by serving as substrate for kinases, enzymes that transfer phosphate groups.  Kinases are the most common ATP-binding proteins.  They share a small number of common folds.<ref name=Scheeff>{{cite journal |last1=Scheeff |first1=E. |last2=Bourne |first2=P. | title = Structural evolution of the protein kinase-like superfamily |pmc=1261164 | doi = 10.1371/journal.pcbi.0010049 | journal = PLoS Comput. Biol. | volume = 1 | issue = 5 | pages = e49 | year = 2005 | pmid = 16244704}}</ref>  [[Phosphorylation]] of a protein by a kinase can activate a cascade such as the [[mitogen-activated protein kinase]] cascade.<ref>{{cite journal |last1=Mishra |first1=N. |last2=Tuteja |first2=R. |last3=Tuteja |first3=N. | title = Signaling through MAP kinase networks in plants | journal = Arch. Biochem. Biophys. | volume = 452 | issue = 1 | pages = 55\u201368 | year = 2006 | pmid = 16806044 | doi = 10.1016/j.abb.2006.05.001 }}</ref>\n\nATP is also a substrate of [[adenylate cyclase]], most commonly in [[G protein\u2013coupled receptor|G protein-coupled receptor]] signal transduction pathways and is transformed to [[second messenger]], cyclic AMP, which is involved in triggering calcium signals by the release of calcium from intracellular stores.<ref>{{cite journal |last1=Kamenetsky |first1=M. |last2=Middelhaufe |first2=S. |last3=Bank |first3=E. |last4=Levin |first4=L. |last5=Buck |first5=J. |last6=Steegborn |first6=C. | title = Molecular details of cAMP generation in mammalian cells: a tale of two systems | journal = J. Mol. Biol. | volume = 362 | issue = 4 | pages = 623\u2013639 | year = 2006 | pmid = 16934836 | doi = 10.1016/j.jmb.2006.07.045 | pmc = 3662476}}</ref> This form of signal transduction is particularly important in brain function, although it is involved in the regulation of a multitude of other cellular processes.<ref>{{cite journal |last1=Hanoune |first1=J. |last2=Defer |first2=N. | title = Regulation and role of adenylyl cyclase isoforms | journal = Annu. Rev. Pharmacol. Toxicol. | volume = 41 | pages = 145\u2013174 | year = 2001| pmid = 11264454 | doi = 10.1146/annurev.pharmtox.41.1.145 }}</ref>\n\n", "attributes": [{"name": "cite journal ", "values": [{"name": "last1", "value": "Scheeff"}, {"name": "first1", "value": "E."}, {"name": "last2", "value": "Bourne"}, {"name": "first2", "value": "P."}, {"name": "title", "value": "Structural evolution of the protein kinase-like superfamily"}, {"name": "pmc", "value": "1261164"}, {"name": "doi", "value": "10.1371/journal.pcbi.0010049"}, {"name": "journal", "value": "PLoS Comput. Biol."}, {"name": "volume", "value": "1"}, {"name": "issue", "value": "5"}, {"name": "pages", "value": "e49"}, {"name": "year", "value": "2005"}, {"name": "pmid", "value": "16244704"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Mishra"}, {"name": "first1", "value": "N."}, {"name": "last2", "value": "Tuteja"}, {"name": "first2", "value": "R."}, {"name": "last3", "value": "Tuteja"}, {"name": "first3", "value": "N."}, {"name": "title", "value": "Signaling through MAP kinase networks in plants"}, {"name": "journal", "value": "Arch. Biochem. Biophys."}, {"name": "volume", "value": "452"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "55\u201368"}, {"name": "year", "value": "2006"}, {"name": "pmid", "value": "16806044"}, {"name": "doi", "value": "10.1016/j.abb.2006.05.001"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Kamenetsky"}, {"name": "first1", "value": "M."}, {"name": "last2", "value": "Middelhaufe"}, {"name": "first2", "value": "S."}, {"name": "last3", "value": "Bank"}, {"name": "first3", "value": "E."}, {"name": "last4", "value": "Levin"}, {"name": "first4", "value": "L."}, {"name": "last5", "value": "Buck"}, {"name": "first5", "value": "J."}, {"name": "last6", "value": "Steegborn"}, {"name": "first6", "value": "C."}, {"name": "title", "value": "Molecular details of cAMP generation in mammalian cells: a tale of two systems"}, {"name": "journal", "value": "J. Mol. Biol."}, {"name": "volume", "value": "362"}, {"name": "issue", "value": "4"}, {"name": "pages", "value": "623\u2013639"}, {"name": "year", "value": "2006"}, {"name": "pmid", "value": "16934836"}, {"name": "doi", "value": "10.1016/j.jmb.2006.07.045"}, {"name": "pmc", "value": "3662476"}]}, {"name": "cite journal ", "values": [{"name": "last1", "value": "Hanoune"}, {"name": "first1", "value": "J."}, {"name": "last2", "value": "Defer"}, {"name": "first2", "value": "N."}, {"name": "title", "value": "Regulation and role of adenylyl cyclase isoforms"}, {"name": "journal", "value": "Annu. Rev. Pharmacol. Toxicol."}, {"name": "volume", "value": "41"}, {"name": "pages", "value": "145\u2013174"}, {"name": "year", "value": "2001"}, {"name": "pmid", "value": "11264454"}, {"name": "doi", "value": "10.1146/annurev.pharmtox.41.1.145"}]}], "id": 18}, {"title": "DNA and RNA synthesis", "paragraphs": "ATP is one of four \"monomers\" required in the synthesis of [[RNA]]. The process is promoted by [[RNA polymerase]]s.<ref>{{cite journal |last1=Joyce |first1=C.&nbsp;M. |last2=Steitz |first2=T.&nbsp;A. |title=Polymerase structures and function: variations on a theme? |journal=J. Bacteriol. |volume=177 |issue=22 |pages=6321\u20136329 |year=1995 |pmid=7592405 |pmc=177480 |doi=10.1128/jb.177.22.6321-6329.1995}}</ref> A similar process occurs in the formation of DNA, except that ATP is first converted to the [[deoxyribonucleotide]] dATP.  Like many condensation reactions in nature, [[DNA replication]] and [[DNA transcription]] also consumes ATP.\n\n", "attributes": [{"name": "cite journal ", "values": [{"name": "last1", "value": "Joyce"}, {"name": "first1", "value": "C.&nbsp;M."}, {"name": "last2", "value": "Steitz"}, {"name": "first2", "value": "T.&nbsp;A."}, {"name": "title", "value": "Polymerase structures and function: variations on a theme?"}, {"name": "journal", "value": "J. Bacteriol."}, {"name": "volume", "value": "177"}, {"name": "issue", "value": "22"}, {"name": "pages", "value": "6321\u20136329"}, {"name": "year", "value": "1995"}, {"name": "pmid", "value": "7592405"}, {"name": "pmc", "value": "177480"}, {"name": "doi", "value": "10.1128/jb.177.22.6321-6329.1995"}]}], "id": 19}, {"title": "Amino acid activation in protein synthesis", "paragraphs": "{{main|Amino acid activation}}\n[[Aminoacyl-tRNA synthetase]] enzymes consume ATP in the attachment tRNA to amino acids, forming aminoacyl-tRNA complexes. Aminoacyl transferase binds AMP-amino acid to tRNA. The coupling reaction proceeds in two steps:\n\n# aa + ATP \u27f6 aa-AMP + [[pyrophosphate|PP<sub>i</sub>]]\n# aa-AMP + tRNA \u27f6 aa-tRNA + AMP\n\nThe amino acid is coupled to the penultimate nucleotide at the 3\u2032-end of the tRNA (the A in the sequence CCA) via an ester bond (roll over in illustration).\n\n", "attributes": [{"name": "main", "values": [{"name": "1", "value": "Amino acid activation"}]}], "id": 20}, {"title": "ATP binding cassette transporter", "paragraphs": "Transporting chemicals out of a cell against a gradient is often associated with ATP hydrolysis.  Transport is mediated by [[ATP binding cassette transporter]]s.  The human genome encodes 48 ABC transporters, that are used for exporting drugs, lipids, and other compounds.<ref>{{cite journal|title=Mammalian ABC transporters in health and disease|authors=Borst, P.; Elferink, R. Oude|journal=Annual Review of Biochemistry|year=2002|volume=71|pages=537\u2013592|doi=10.1146/annurev.biochem.71.102301.093055|pmid=12045106|url=https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf|access-date=2018-04-20|archive-url=https://web.archive.org/web/20180421032744/https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf|archive-date=2018-04-21|url-status=live}}</ref>\n\n", "attributes": [{"name": "cite journal", "values": [{"name": "title", "value": "Mammalian ABC transporters in health and disease"}, {"name": "authors", "value": "Borst, P.; Elferink, R. Oude"}, {"name": "journal", "value": "Annual Review of Biochemistry"}, {"name": "year", "value": "2002"}, {"name": "volume", "value": "71"}, {"name": "pages", "value": "537\u2013592"}, {"name": "doi", "value": "10.1146/annurev.biochem.71.102301.093055"}, {"name": "pmid", "value": "12045106"}, {"name": "url", "value": "https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf"}, {"name": "access-date", "value": "2018-04-20"}, {"name": "archive-url", "value": "https://web.archive.org/web/20180421032744/https://pure.uva.nl/ws/files/3499814/42885_202387y.pdf"}, {"name": "archive-date", "value": "2018-04-21"}, {"name": "url-status", "value": "live"}]}], "id": 21}, {"title": "Extracellular signalling and neurotransmision", "paragraphs": "Cells secrete ATP to communicate with other cells in a process called [[purinergic signalling]]. ATP serves as a neurotransmitter in many parts of the nervous system, modulates ciliary beating, affects vascular oxygen supply etc.  ATP is either secreted directly across the cell membrane through channel proteins<ref name=\"RomanovLasher2018\">{{cite journal|last1=Romanov|first1=Roman A.|last2=Lasher|first2=Robert S.|last3=High|first3=Brigit|last4=Savidge|first4=Logan E.|last5=Lawson|first5=Adam|last6=Rogachevskaja|first6=Olga A.|last7=Zhao|first7=Haitian|last8=Rogachevsky|first8=Vadim V.|last9=Bystrova|first9=Marina F.|last10=Churbanov|first10=Gleb D.|last11=Adameyko|first11=Igor|last12=Harkany|first12=Tibor|last13=Yang|first13=Ruibiao|last14=Kidd|first14=Grahame J.|last15=Marambaud|first15=Philippe|last16=Kinnamon|first16=John C.|last17=Kolesnikov|first17=Stanislav S.|last18=Finger|first18=Thomas E.|title=Chemical synapses without synaptic vesicles: Purinergic neurotransmission through a CALHM1 channel-mitochondrial signaling complex|journal=Science Signaling|volume=11|issue=529|year=2018|pages=eaao1815|issn=1945-0877|doi=10.1126/scisignal.aao1815|pmid=29739879|pmc=5966022}}</ref><ref name=\"Dahl2015\">{{cite journal|last1=Dahl|first1=Gerhard|title=ATP release through pannexon channels|journal=Philosophical Transactions of the Royal Society B: Biological Sciences|volume=370|issue=1672|year=2015|pages=20140191|issn=0962-8436|doi=10.1098/rstb.2014.0191|pmid=26009770|pmc=4455760}}</ref> or is pumped into vesicles<ref name=\"LarssonSawada2012\">{{cite journal|last1=Larsson|first1=Max|last2=Sawada|first2=Keisuke|last3=Morland|first3=Cecilie|last4=Hiasa|first4=Miki|last5=Ormel|first5=Lasse|last6=Moriyama|first6=Yoshinori|last7=Gundersen|first7=Vidar|title=Functional and Anatomical Identification of a Vesicular Transporter Mediating Neuronal ATP Release|journal=Cerebral Cortex|volume=22|issue=5|year=2012|pages=1203\u20131214|issn=1460-2199|doi=10.1093/cercor/bhr203|pmid=21810784}}</ref> which then [[exocytosis|fuse]] with the membrane. Cells detect ATP using the [[purinergic receptor]] proteins P2X and P2Y.\n\n", "attributes": [{"name": "cite journal", "values": [{"name": "last1", "value": "Romanov"}, {"name": "first1", "value": "Roman A."}, {"name": "last2", "value": "Lasher"}, {"name": "first2", "value": "Robert S."}, {"name": "last3", "value": "High"}, {"name": "first3", "value": "Brigit"}, {"name": "last4", "value": "Savidge"}, {"name": "first4", "value": "Logan E."}, {"name": "last5", "value": "Lawson"}, {"name": "first5", "value": "Adam"}, {"name": "last6", "value": "Rogachevskaja"}, {"name": "first6", "value": "Olga A."}, {"name": "last7", "value": "Zhao"}, {"name": "first7", "value": "Haitian"}, {"name": "last8", "value": "Rogachevsky"}, {"name": "first8", "value": "Vadim V."}, {"name": "last9", "value": "Bystrova"}, {"name": "first9", "value": "Marina F."}, {"name": "last10", "value": "Churbanov"}, {"name": "first10", "value": "Gleb D."}, {"name": "last11", "value": "Adameyko"}, {"name": "first11", "value": "Igor"}, {"name": "last12", "value": "Harkany"}, {"name": "first12", "value": "Tibor"}, {"name": "last13", "value": "Yang"}, {"name": "first13", "value": "Ruibiao"}, {"name": "last14", "value": "Kidd"}, {"name": "first14", "value": "Grahame J."}, {"name": "last15", "value": "Marambaud"}, {"name": "first15", "value": "Philippe"}, {"name": "last16", "value": "Kinnamon"}, {"name": "first16", "value": "John C."}, {"name": "last17", "value": "Kolesnikov"}, {"name": "first17", "value": "Stanislav S."}, {"name": "last18", "value": "Finger"}, {"name": "first18", "value": "Thomas E."}, {"name": "title", "value": "Chemical synapses without synaptic vesicles: Purinergic neurotransmission through a CALHM1 channel-mitochondrial signaling complex"}, {"name": "journal", "value": "Science Signaling"}, {"name": "volume", "value": "11"}, {"name": "issue", "value": "529"}, {"name": "year", "value": "2018"}, {"name": "pages", "value": "eaao1815"}, {"name": "issn", "value": "1945-0877"}, {"name": "doi", "value": "10.1126/scisignal.aao1815"}, {"name": "pmid", "value": "29739879"}, {"name": "pmc", "value": "5966022"}]}, {"name": "cite journal", "values": [{"name": "last1", "value": "Dahl"}, {"name": "first1", "value": "Gerhard"}, {"name": "title", "value": "ATP release through pannexon channels"}, {"name": "journal", "value": "Philosophical Transactions of the Royal Society B: Biological Sciences"}, {"name": "volume", "value": "370"}, {"name": "issue", "value": "1672"}, {"name": "year", "value": "2015"}, {"name": "pages", "value": "20140191"}, {"name": "issn", "value": "0962-8436"}, {"name": "doi", "value": "10.1098/rstb.2014.0191"}, {"name": "pmid", "value": "26009770"}, {"name": "pmc", "value": "4455760"}]}, {"name": "cite journal", "values": [{"name": "last1", "value": "Larsson"}, {"name": "first1", "value": "Max"}, {"name": "last2", "value": "Sawada"}, {"name": "first2", "value": "Keisuke"}, {"name": "last3", "value": "Morland"}, {"name": "first3", "value": "Cecilie"}, {"name": "last4", "value": "Hiasa"}, {"name": "first4", "value": "Miki"}, {"name": "last5", "value": "Ormel"}, {"name": "first5", "value": "Lasse"}, {"name": "last6", "value": "Moriyama"}, {"name": "first6", "value": "Yoshinori"}, {"name": "last7", "value": "Gundersen"}, {"name": "first7", "value": "Vidar"}, {"name": "title", "value": "Functional and Anatomical Identification of a Vesicular Transporter Mediating Neuronal ATP Release"}, {"name": "journal", "value": "Cerebral Cortex"}, {"name": "volume", "value": "22"}, {"name": "issue", "value": "5"}, {"name": "year", "value": "2012"}, {"name": "pages", "value": "1203\u20131214"}, {"name": "issn", "value": "1460-2199"}, {"name": "doi", "value": "10.1093/cercor/bhr203"}, {"name": "pmid", "value": "21810784"}]}], "id": 22}, {"title": " Protein solubility ", "paragraphs": "ATP has recently been proposed to act as a biological [[hydrotrope]]<ref>{{Cite journal|last=Hyman|first=Anthony A.|last2=Krishnan|first2=Yamuna|last3=Alberti|first3=Simon|last4=Wang|first4=Jie|last5=Saha|first5=Shambaditya|last6=Malinovska|first6=Liliana|last7=Patel|first7=Avinash|date=2017-05-19|title=ATP as a biological hydrotrope|journal=Science|language=en|volume=356|issue=6339|pages=753\u2013756|doi=10.1126/science.aaf6846|issn=0036-8075|pmid=28522535}}</ref> and has been shown to affect proteome-wide solubility.<ref>{{Cite journal|last=Savitski|first=Mikhail M.|last2=Bantscheff|first2=Marcus|last3=Huber|first3=Wolfgang|last4=Dominic Helm|last5=G\u00fcnthner|first5=Ina|last6=Werner|first6=Thilo|last7=Kurzawa|first7=Nils|last8=Sridharan|first8=Sindhuja|date=2019-03-11|title=Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP|journal=Nature Communications|language=en|volume=10|issue=1|pages=1155|doi=10.1038/s41467-019-09107-y|pmid=30858367|pmc=6411743|issn=2041-1723}}</ref>\n\n", "attributes": [{"name": "Cite journal", "values": [{"name": "last", "value": "Hyman"}, {"name": "first", "value": "Anthony A."}, {"name": "last2", "value": "Krishnan"}, {"name": "first2", "value": "Yamuna"}, {"name": "last3", "value": "Alberti"}, {"name": "first3", "value": "Simon"}, {"name": "last4", "value": "Wang"}, {"name": "first4", "value": "Jie"}, {"name": "last5", "value": "Saha"}, {"name": "first5", "value": "Shambaditya"}, {"name": "last6", "value": "Malinovska"}, {"name": "first6", "value": "Liliana"}, {"name": "last7", "value": "Patel"}, {"name": "first7", "value": "Avinash"}, {"name": "date", "value": "2017-05-19"}, {"name": "title", "value": "ATP as a biological hydrotrope"}, {"name": "journal", "value": "Science"}, {"name": "language", "value": "en"}, {"name": "volume", "value": "356"}, {"name": "issue", "value": "6339"}, {"name": "pages", "value": "753\u2013756"}, {"name": "doi", "value": "10.1126/science.aaf6846"}, {"name": "issn", "value": "0036-8075"}, {"name": "pmid", "value": "28522535"}]}, {"name": "Cite journal", "values": [{"name": "last", "value": "Savitski"}, {"name": "first", "value": "Mikhail M."}, {"name": "last2", "value": "Bantscheff"}, {"name": "first2", "value": "Marcus"}, {"name": "last3", "value": "Huber"}, {"name": "first3", "value": "Wolfgang"}, {"name": "last4", "value": "Dominic Helm"}, {"name": "last5", "value": "G\u00fcnthner"}, {"name": "first5", "value": "Ina"}, {"name": "last6", "value": "Werner"}, {"name": "first6", "value": "Thilo"}, {"name": "last7", "value": "Kurzawa"}, {"name": "first7", "value": "Nils"}, {"name": "last8", "value": "Sridharan"}, {"name": "first8", "value": "Sindhuja"}, {"name": "date", "value": "2019-03-11"}, {"name": "title", "value": "Proteome-wide solubility and thermal stability profiling reveals distinct regulatory roles for ATP"}, {"name": "journal", "value": "Nature Communications"}, {"name": "language", "value": "en"}, {"name": "volume", "value": "10"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "1155"}, {"name": "doi", "value": "10.1038/s41467-019-09107-y"}, {"name": "pmid", "value": "30858367"}, {"name": "pmc", "value": "6411743"}, {"name": "issn", "value": "2041-1723"}]}], "id": 23}, {"title": "ATP analogues", "paragraphs": "Biochemistry laboratories often use ''[[in vitro]]'' studies to explore ATP-dependent molecular processes. ATP analogs are also used in [[X-ray crystallography]] to determine a [[protein structure]] in complex with ATP, often together with other substrates.\n\n[[Enzyme inhibitor]]s of ATP-dependent enzymes such as [[kinase]]s are needed to examine the [[binding site]]s and [[transition state]]s involved in ATP-dependent reactions.\n\nMost useful ATP analogs cannot be hydrolyzed as ATP would be; instead they trap the enzyme in a structure closely related to the ATP-bound state. Adenosine 5\u2032-(\u03b3-thiotriphosphate) is an extremely common ATP analog in which one of the gamma-phosphate oxygens is replaced by a [[sulfur]] atom; this anion is hydrolyzed at a dramatically slower rate than ATP itself and functions as an inhibitor of ATP-dependent processes. In crystallographic studies, hydrolysis transition states are modeled by the bound [[vanadate]] ion.\n\nCaution is warranted in interpreting the results of experiments using ATP analogs, since some enzymes can hydrolyze them at appreciable rates at high concentration.<ref name=Resetar>{{cite journal |last1=Resetar |first1=A.&nbsp;M. |last2=Chalovich |first2=J.&nbsp;M. | year=1995 | title= Adenosine 5\u2032-(gamma-thiotriphosphate): an ATP analog that should be used with caution in muscle contraction studies | volume=34 | issue=49 | pages=16039\u201316045 | pmid=8519760 | doi = 10.1021/bi00049a018 | journal= Biochemistry}}</ref>\n\n", "attributes": [{"name": "cite journal ", "values": [{"name": "last1", "value": "Resetar"}, {"name": "first1", "value": "A.&nbsp;M."}, {"name": "last2", "value": "Chalovich"}, {"name": "first2", "value": "J.&nbsp;M."}, {"name": "year", "value": "1995"}, {"name": "title", "value": "Adenosine 5\u2032-(gamma-thiotriphosphate): an ATP analog that should be used with caution in muscle contraction studies"}, {"name": "volume", "value": "34"}, {"name": "issue", "value": "49"}, {"name": "pages", "value": "16039\u201316045"}, {"name": "pmid", "value": "8519760"}, {"name": "doi", "value": "10.1021/bi00049a018"}, {"name": "journal", "value": "Biochemistry"}]}], "id": 24}, {"title": "History", "paragraphs": "ATP was discovered in 1929 by [[w:de:Karl Lohmann (Biochemiker)|Karl Lohmann]]<ref>{{cite journal |last=Lohmann |first=K. |title=\u00dcber die Pyrophosphatfraktion im Muskel |trans-title=On the pyrophosphate fraction in muscle |journal=Naturwissenschaften |volume=17 |issue=31 |pages=624\u2013625 |date=August 1929 |doi=10.1007/BF01506215 |language=German}}</ref> and Jendrassik<ref>{{cite journal| title=The Determination of Phosphorus and the Discovery of Phosphocreatine and ATP: the Work of Fiske and SubbaRow| journal=Journal of Biological Chemistry| volume=277| issue=32| pages=e21| url=http://www.jbc.org/content/277/32/e21| year=2002| last1=Vaughan| first1=Martha| last2=Hill| first2=Robert L.| last3=Simoni| first3=Robert D.| access-date=2017-10-24| archive-url=https://web.archive.org/web/20170808062708/http://www.jbc.org/content/277/32/e21| archive-date=2017-08-08| url-status=live}}</ref> and, independently, by Cyrus Fiske and [[Yellapragada Subba Rao]] of [[Harvard Medical School]],<ref>{{cite journal |last=Maruyama |first=K. |title=The discovery of adenosine triphosphate and the establishment of its structure |journal=J. Hist. Biol. |volume=24 |issue=1 |pages=145\u2013154 |date=March 1991 |doi=10.1007/BF00130477 }}</ref> both teams competing against each other to find an assay for phosphorus.\n\nIt was proposed to be the intermediary between energy-yielding and energy-requiring reactions in cells by [[Fritz Albert Lipmann]] in 1941.<ref>{{cite journal |last=Lipmann |first=F. |title=Metabolic generation and utilization of phosphate bond energy.  |journal=Adv. Enzymol. |volume=1 |pages=99\u2013162 |year=1941 |issn=0196-7398}}</ref>\n\nIt was first synthesized in the laboratory by [[Alexander R. Todd, Baron Todd|Alexander Todd]] in 1948.<ref>{{cite web| url=http://nobelprize.org/nobel_prizes/chemistry/laureates/1997/illpres/history.html| work=The Nobel Prize in Chemistry 1997| title=History: ATP first discovered in 1929| publisher=[[Nobel Foundation]]| accessdate=2010-05-26| archive-url=https://web.archive.org/web/20100123061355/http://nobelprize.org/nobel_prizes/chemistry/laureates/1997/illpres/history.html| archive-date=2010-01-23| url-status=live}}</ref>\n\nThe [[Nobel Prize in Chemistry]] 1997 was divided, one half jointly to [[Paul D. Boyer]] and [[John E. Walker]] \"''for their elucidation of the enzymatic mechanism underlying the synthesis of adenosine triphosphate (ATP)''\" and the other half to [[Jens C. Skou]] \"''for the first discovery of an ion-transporting enzyme, Na+, K+ -ATPase''.\"<ref>{{cite web|url=https://www.nobelprize.org/nobel_prizes/chemistry/laureates/1997/|title=The Nobel Prize in Chemistry 1997|website=www.nobelprize.org|accessdate=21 January 2018|archive-url=https://web.archive.org/web/20171024205633/https://www.nobelprize.org/nobel_prizes/chemistry/laureates/1997/|archive-date=24 October 2017|url-status=live}}</ref>\n{{clear}}\n\n", "attributes": [{"name": "cite journal ", "values": [{"name": "last", "value": "Lohmann"}, {"name": "first", "value": "K."}, {"name": "title", "value": "\u00dcber die Pyrophosphatfraktion im Muskel"}, {"name": "trans-title", "value": "On the pyrophosphate fraction in muscle"}, {"name": "journal", "value": "Naturwissenschaften"}, {"name": "volume", "value": "17"}, {"name": "issue", "value": "31"}, {"name": "pages", "value": "624\u2013625"}, {"name": "date", "value": "August 1929"}, {"name": "doi", "value": "10.1007/BF01506215"}, {"name": "language", "value": "German"}]}, {"name": "cite journal", "values": [{"name": "title", "value": "The Determination of Phosphorus and the Discovery of Phosphocreatine and ATP: the Work of Fiske and SubbaRow"}, {"name": "journal", "value": "Journal of Biological Chemistry"}, {"name": "volume", "value": "277"}, {"name": "issue", "value": "32"}, {"name": "pages", "value": "e21"}, {"name": "url", "value": "http://www.jbc.org/content/277/32/e21"}, {"name": "year", "value": "2002"}, {"name": "last1", "value": "Vaughan"}, {"name": "first1", "value": "Martha"}, {"name": "last2", "value": "Hill"}, {"name": "first2", "value": "Robert L."}, {"name": "last3", "value": "Simoni"}, {"name": "first3", "value": "Robert D."}, {"name": "access-date", "value": "2017-10-24"}, {"name": "archive-url", "value": "https://web.archive.org/web/20170808062708/http://www.jbc.org/content/277/32/e21"}, {"name": "archive-date", "value": "2017-08-08"}, {"name": "url-status", "value": "live"}]}, {"name": "cite journal ", "values": [{"name": "last", "value": "Maruyama"}, {"name": "first", "value": "K."}, {"name": "title", "value": "The discovery of adenosine triphosphate and the establishment of its structure"}, {"name": "journal", "value": "J. Hist. Biol."}, {"name": "volume", "value": "24"}, {"name": "issue", "value": "1"}, {"name": "pages", "value": "145\u2013154"}, {"name": "date", "value": "March 1991"}, {"name": "doi", "value": "10.1007/BF00130477"}]}, {"name": "cite journal ", "values": [{"name": "last", "value": "Lipmann"}, {"name": "first", "value": "F."}, {"name": "title", "value": "Metabolic generation and utilization of phosphate bond energy."}, {"name": "journal", "value": "Adv. Enzymol."}, {"name": "volume", "value": "1"}, {"name": "pages", "value": "99\u2013162"}, {"name": "year", "value": "1941"}, {"name": "issn", "value": "0196-7398"}]}, {"name": "cite web", "values": [{"name": "url", "value": "http://nobelprize.org/nobel_prizes/chemistry/laureates/1997/illpres/history.html"}, {"name": "work", "value": "The Nobel Prize in Chemistry 1997"}, {"name": "title", "value": "History: ATP first discovered in 1929"}, {"name": "publisher", "value": "[[Nobel Foundation]]"}, {"name": "accessdate", "value": "2010-05-26"}, {"name": "archive-url", "value": "https://web.archive.org/web/20100123061355/http://nobelprize.org/nobel_prizes/chemistry/laureates/1997/illpres/history.html"}, {"name": "archive-date", "value": "2010-01-23"}, {"name": "url-status", "value": "live"}]}, {"name": "cite web", "values": [{"name": "url", "value": "https://www.nobelprize.org/nobel_prizes/chemistry/laureates/1997/"}, {"name": "title", "value": "The Nobel Prize in Chemistry 1997"}, {"name": "website", "value": "www.nobelprize.org"}, {"name": "accessdate", "value": "21 January 2018"}, {"name": "archive-url", "value": "https://web.archive.org/web/20171024205633/https://www.nobelprize.org/nobel_prizes/chemistry/laureates/1997/"}, {"name": "archive-date", "value": "24 October 2017"}, {"name": "url-status", "value": "live"}]}], "id": 25}, {"title": "See also", "paragraphs": "{{col div|colwidth=30em}}\n* [[Adenosine diphosphate]] (ADP)\n* [[Adenosine monophosphate]] (AMP)\n* [[Adenosine-tetraphosphatase]]\n* [[NDPCP|Adenosine methylene triphosphate]]\n* [[ATPases]]\n* [[ATP test]]\n* [[ATP hydrolysis]]\n* [[Citric acid cycle]] (also called the Krebs cycle or TCA cycle)\n* [[Creatine]]\n* [[Cyclic adenosine monophosphate]] (cAMP)\n* [[Nucleotide exchange factor]]\n* [[Phosphagen]]\n* [[Photophosphorylation]]\n{{colend}}\n\n", "attributes": [{"name": "col div", "values": [{"name": "colwidth", "value": "30em"}]}], "id": 26}, {"title": "References", "paragraphs": "{{Reflist|30em}}\n\n", "attributes": [{"name": "Reflist", "values": [{"name": "1", "value": "30em"}]}], "id": 27}, {"title": "External links", "paragraphs": "{{Commons category|Adenosine triphosphate}}\n* [http://www.ebi.ac.uk/pdbe-srv/PDBeXplore/ligand/?ligand=ATP ATP bound to proteins] in the [[Protein Data Bank|PDB]]\n* [https://web.archive.org/web/20160310134410/http://www.scienceaid.co.uk/biology/biochemistry/atp.html ScienceAid: Energy ATP and Exercise]\n* [https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=5957 PubChem entry for Adenosine Triphosphate]\n* [http://www.genome.jp/dbget-bin/www_bget?cpd:C00002 KEGG entry for Adenosine Triphosphate]\n\n{{Nucleobases, nucleosides, and nucleotides}}\n{{Enzyme cofactors}}\n{{Neurotransmitters}}\n{{Food science}}\n{{Cellular respiration}}\n{{MetabolismMap}}\n\n{{Authority control}}\n\n{{DEFAULTSORT:Adenosine phosphate3}}\n[[Category:Adenosine receptor agonists]]\n[[Category:Neurotransmitters]]\n[[Category:Purinergic signalling]]\n[[Category:Cellular respiration]]\n[[Category:Exercise physiology]]\n[[Category:Nucleotides]]\n[[Category:Coenzymes]]\n[[Category:Purines]]\n[[Category:Ergogenic aids]]", "attributes": [{"name": "Commons category", "values": [{"name": "1", "value": "Adenosine triphosphate"}]}], "id": 28}]}